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 A dual plasmid system for the incorporation of unnatural amino acids into plant 
pathogen, Pseudomonas syringae pv. tomato DC3000, has been designed.  This invention is 
expected to allow (a) mutations of proteins synthesized by the bacterium, P. syringae pv. tomato 
DC3000, that can capture molecular targets, especially for such modified proteins secreted by the 
phytopathogen into the host plant cells of A. thaliana and S. lycopersicum, (b) expression of 
biological probes in the bacterial species to monitor changes in redox, nutritional, and other small 
molecule states over pre-, post- and in situ disease stages, and (c) secretion of such biological 
probes into an infection host organism to monitor intracellular changes of redox, nutritional, and 
small molecule states in infected host.  This plasmid system will allow proteins to feature 
unnatural amino acids in substitution for selected original residues by site-specific alteration of 
the protein sequence to the TAG stop codon for recognition exogenous and orthogonal TAG-
suppressing tRNA that has been charged with the unnatural amino acid by its cognate tRNA 
synthetase (RS).  Because the suppressor tRNA and its counterpart synthetase are designed to 
only interact with each other, proteins expressed by the bacterial species containing this 
orthogonal tRNA/RS pair will enable in vivo production of proteins featuring specialized disease-
based monitoring capabilities.  In addition, this plasmid system is expected to be compatible not 
only with other pathovars of the P. syringae genus, but also other phytopathogens and soil 
 bacteria, thereby significantly enhancing the researcher’s ability to understand the role and 
response of these microorganisms within their environment.
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Chapter 1 – Introduction and Specific Aims 
1.1 General Introduction 
Understanding host-pathogen interactions at a molecular level requires ability to identify 
which proteins or small molecules are involved in the communication within and between the two 
species.  Within the host, for instance, signal pathways for normal growth will become altered 
once a stress – whether physical, biological, or chemical – has affected the organism.  The 
response to stress must allow the host species to maintain its normal processes while altering the 
local or systemic regions to remedy and repair the self.  An entity that directs all of its resources 
to stress response and does not maintain normal survival processes will likely suffer and die.  
Likewise, the pathogen species must keep its own normal processes functioning while it attempts 
invasion of the host and with the host’s response for immunity, the pathogen also becomes 
stressed.  Indeed, disease events could be seen as an aggressive form of communication where 
both entities share a region of immediate interaction, or front line, behind which both species 
must organize their secondary preparations and, as the altercation continues, sustain their own 
bodies in the event that the battle should end.  Immediately, the host or pathogen must  begin 
repair and subsequent growth, allowing for reproduction and, if necessary, further defense (or 
offense) against additional forces.  It is not surprising, then, that approaching the disease event 
with the perspective of warfare should yield tactics (i.e. espionage) for understanding the 
behavior of the players involved and, especially, their respective mechanisms for battle. 
It has been shown (Hueck, 1998; Ronald, 2010) that in bacterial diseases of animals or 
plants, all classes of biological molecules (e.g. DNA and RNA, proteins, lipid membranes, 
polysaccharides, and various signaling molecules) are involved in this hostile tête–à–tête.  
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Therefore, the need to understand the chromosomal, transcript, and protein-based responses are 
important for recognizing the mechanisms of disease, especially, interactive partners in signaling.   
Many pathogens that infect animal or plant hosts are able to manipulate their host’s 
cellular activity and structure by secretion of proteins and small molecules into the host cell 
bodies.  The plant pathogen, Pseudomonas syringae, secretes proteins through a Type III 
secretion system – a needle-like apparatus constructed outside the bacteria that creates a portal 
into the host cell (Figure 1).  This system allows a direct extracellular tunnel between the 
bacterial cytosol and the host cytosol such than any secreted proteins, called effector proteins, can 
be transported quickly into the host cell body and exert effects to modify the invaded species.  
Effector proteins secreted by this system features a secretion-specific terminus peptide sequence 
to help the bacterial body properly transport and export the protein into the extracellular 
apparatus.  It is noted that in virulent bacterial species there are different types of secretion 
systems, classified as Type I, II, III, IV, V, a Type VI system (which secretes into both bacterial 
and eukaryotic cells) and even a Gram-positive Type VII system (Tseng, 2009; Russell, 2014).  
These secretion methods are different than the more common mechanisms in both pathogenic and 
non-pathogenic species, such as the Sec-dependent (Pugsley, 1993) and Twin-arginine 
translocation system (Bronstein, 2005).  Most systems feature an export apparatus for proteins or 
small molecules to promote survival of the bacterial pathogen in its new host environment.  The 
Type IV system, for instance, allows the Agrobacterium tumefaciens to export its Ti (tumor-
inducing) plasmid into the stalk of the host-plant body, allowing for DNA-based alteration of the 
host (Gelvin, 2003); this method, incidentally, has been exploited to impart resistance in tomato 
plants from the tobacco mosaic virus, showing that a pathogen’s tool-set can also be a useful tool 
for humans.    The Type III system mechanism can likewise be exploited as a useful tool. 
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Figure 1:  Illustration showing constructed Type III secretion system extending from bacterial 
pathogen into plant host cell wall.  Also depicted is a generic effector protein (red circle) passing 
from invader into infected organism (adapted from Buttner, 2009). 
One particular strain of the P. syringae family is P. syringae pv. tomato DC3000 
(DC3000), is capable of infecting both its natural host, the tomato plant, and the model plant 
Arabidopsis thaliana.  The natural host suffers from bacterial black speck (Hueck, 1998), which 
causes lesions on leaves and fruits of the tomato plant and resulting in lower harvest and storage 
(Cuppels, 1986), while A. thaliana infection produces chlorosis, wilting, and subsequent death 
(Katagiri, 2002).  Like many other pathogens, DC3000 constructs an effector secretion apparatus 
after infiltrating the host body and exports macromolecules into the host cell cytosol.  The 
DC3000 Type III secretion system is recorded to secrete at least 40 proteins (Cunnac, 2009), 
including several that aide in building the pathway from pathogen to host (e.g. harpin proteins), 
and some of which work in concert with host native machinery to shift the host’s awareness and 
growth phase.  A number of secreted effectors require post-translational modification from host 
proteins before being able to cause their intended effects.   
Currently, there are many effector proteins with unknown targets and it is therefore 
important to identify the host substrates for these proteins.  Understanding the target of each 
effector will help to uncover the dynamics of the molecular basis of disease as caused by 
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DC3000.  To aide in understanding this basis, the ability to capture a target in situ will be of 
greatest benefit, as some protein targets may not be expressed except during the infection process.  
However, it is also useful to pinpoint effector proteins in their post-infection location while still 
contained within the host cell as this would also shed light on the disease process.  A salient 
methodology to allow for both methods of analysis, as well as studying pathogen-specific events 
leading to and during infection, involves the incorporation of unnatural amino acids (UAA) into 
those effector proteins, thereby allowing them to become tools for researchers to study the 
pathogen-host system in finer detail.  For example, covalent binding of an effector to its target(s) 
through use of a crosslinking amino acid (e.g. phenylalanine derivatives featuring benzophenone 
or azido substituents; Figure 2), would produce an extractable complex from the lysate of the 
host-pathogen cellular mixture.  The effector-target complex can be examined to reveal the 
protein (or small molecule) counterpart to the bacterial secreted protein.  In addition, other amino 
acids with different functionality could be used for study, as has been shown in recent literature 
(Wang, 2003; Ryu, 2006; Liu, 2010; Coin, 2011).  
 
Figure 2:  Crosslinking phenylalanine derivatives, p-azido-L-phenylalanine (AzF; left) and p-
benzoyl-L-phenylalanine (BpF; right).  
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The general methodology for producing proteins with unnatural amino acids was 
developed by the group of Peter G. Schultz in the early 1990’s (for review: Liu, 2010).  The 
process allows for in vivo production of peptides and proteins using uniquely interacting tRNA 
and tRNA synthetase (RS) pairs, thereby allowing synthesis of polypeptides featuring unnatural 
(or alternative) amino acids inserted at the point of an introduced stop codon.  The TAG stop 
codon is the most frequently used premature stopping site due to its low frequency in most 
chromosomes (Povolotskaya, 2012).  The DNA sequence for the protein of study is altered by 
site-directed mutagenesis to change, for example, a tyrosine residue’s TAT codon to TAG, and 
attempted translation from mRNA transcript for this mutated protein would produce a truncated 
(and generally inactive) protein.  Selection of the amino acid sequence for modification to a stop 
codon is dictated by the residue’s location in the protein’s tertiary structure – to allow for 
proximity of a target protein – as well as the residue’s role in native protein folding.  Altering a 
proline residue to BpF, for instance, would likely reduce chance of proper protein folding even 
though the surface position of the residue would be the same for protein-protein contact, as 
proline generally provides for a specific kink in the molecule’s folded structure. 
  After successful codon mutation, a pre-selected TAG-specific exogenous tRNA and its 
corresponding RS, are then expressed in the organism that produces the mutant protein’s 
nucleotide sequence.  Upon recognition of the TAG stop codon by this tRNA, premature 
polypeptide termination is not engaged, but instead the RS-specific UAA is charged to the 
exogenous tRNA and the polypeptide sequence is translated to the full-length protein (Figure 3). 
6 
 
 
 
Figure 3:  Illustration to show the effect of orthogonal tRNA and synthetase pair for in vivo 
incorporation of an unnatural amino acid (shown as red circle) into protein during translation.  
Left-hand molecular species (black) are the native machinery in the organism, while the right-
hand species (red) are the exogenous and orthogonal tRNA and corresponding synthetase 
(retrieved from Wang, 2005). 
1.2 Project Overview and Specific Aims 
With UAA-incorporation technology, modified forms of effector proteins can be 
synthesized within the pathogen and secreted directly into the host cell.  This method of in vivo 
capture helps to ensure proper location and targeting of effector proteins.  In the event an 
effector’s target is not produced at a high concentration except during the disease state, pathogen-
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initiation of infection would promote more available target amount for access and capture.  A 
two-plasmid system has thus been developed to allow for the incorporation of unnatural amino 
acids into the plant pathogen, Pseudomonas syringae pv. tomato DC3000, with the intent of 
capturing effector targets in planta. 
A pair of plasmids is used to individually control the transcription of the exogenous 
tRNA and protein of interest, and, separately, the corresponding synthetase.  Both the tRNA and 
synthetase must be unable to interact with the native DC3000 protein synthesis machinery and so 
two sets of plasmid pairs were selected from Archaea, as these are not expected to interact with 
eubacterial machinery (Yanagisawa, 2008; Wang, 2010): Methanosarcina spp. which utilize a 
pyrrolysine-tRNA/synthetase to naturally suppress TAG codons, and the anti-codon mutated 
tyrosyl-tRNA and mutated synthetase from Methanocaldococcus jannaschii.   For both sets of 
plasmid pairs, the tRNA and GFP reporter protein are both on the same plasmids, pBBR1MCS3 
(Kovach, 1995), and the synthetase is expressed from pML123 (Labes, 1990).  Both of these 
parent vectors were provided by James Alfano (University of Nebraska-Lincoln).   
The pBBR1MCS3 vector (Tet
R; 
Figure 4) was chosen for housing a GFPuv reporter 
protein and the exogenous tRNA.  The reporter protein shows fluorescence when fully folded and 
a mutation at position, N149, to TAG stop codon (GAU  TAG) yields premature termination of 
the translated peptide sequence and thus would produce no full-length or fluorescing protein. 
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Figure 4:  Plasmid map for pBBR1MCS3 vector for tRNA, GFPuv constructs.  {Kovach, 1995} 
The pML123 vector (Gen
R; 
Figure 5) from pML10 family is used as the synthetase vector 
for which several promoters have been positioned upstream the multiple cloning site (Table II, 
Labes, 1990).  Vector pML123 (and pML122) possesses neomycin acetyltransferase promoter 
and terminator regions to yield strong promotion in soil bacteria, but not E. coli.  Therefore, 
pML123 was modified to feature tac and T5 promoters and their corresponding ribosome binding 
sites in this study, expecting moderate expression in both E. coli and P. syringae DC3000.   
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Figure 5:  Plasmid map for pML123 vector for synthetase constructs.  {Labes, 1990} 
1.2.1 Methanosarcina barkeri Pyl-tRNA
CUA 
and Methanosarcina mazei Pyl-tRNA Synthetase 
Several Methanosarcina spp. utilize an unusual amino acid, pyrrolysine, and possess 
unique tRNA and synthetase pairs for incorporation of this amino acid in their biological 
framework.  The native anticodon arm (CUA) for the pyrrolysyl-tRNA recognizes the codon, 
TAG (Srinivasan, 2002). 
This thesis study employs the pyrrolysyl-tRNA (Pyl-tRNA) to recognize the TAG stop 
codon and a cognate synthetase developed (Yanagisawa, 2008) for incorporation of unnatural 
amino acids, including a boc-protected lysine, which can be inserted into proteins of study.  
Investigations involved use of the wild-type cognate pyrrolysine-tRNA synthetase (PylRS), a 
mutant with higher affinity for boc-lysine (PylRS Y348F), and a mutant evolved to better 
recognize natural amino acids (PylRS NAA, or PylRS
NAA
).  Pyl-tRNA/RS pair was the first 
studied in P. syringae DC3000, to investigate the tRNA transcription under native DC3000 tRNA-
met-3 promoter and terminator regions.  This tRNA expression was the first step in successful 
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incorporation of UAAs.  In addition, this project also utilizes different promoters for the 
synthetase plasmid (tac and T5) in attempt to enhance RS expression in P. syringae DC3000. 
1.2.2 Methanocaldococcus jannaschii Tyrosyl-tRNA
CUA
 and Evolved M. jannaschii Synthetase 
A dual plasmid system was also designed to feature M. jannaschii Tyr-tRNA
CUA 
and 
cognate synthetase, by which the wild-type tyrosyl-tRNA synthetase (TyrRS WT), and two 
evolved RS specific for either p-benzoyl-L-phenylalanine (BpF) or p-azido-L-phenylalanine 
(AzF) were analyzed separately.  Both the BpF and AzF amino acid derivatives of phenylalanine 
have been shown to yield successful covalent capture of protein targets (Chin, 2002; Chin, 2002). 
Further study involved modifying the M. jannaschii Tyr-tRNA promoter sequences to 
alter product transcription.  The prokaryotic promoters, lpp, an upstream promoter for the E. coli 
outer membrane lipoprotein (Inouye, 1985), and proK, featured in the E. coli prolyl-tRNA codon 
(Ryu, 2006) were chosen for this procedure.  Our laboratory possessed vectors which contained 
the Tyr-tRNA already downstream the lpp or proK promoters, as well as all tRNA/RS pairs.   
Although successful expression of the full-length mutant GFPuv N149TAG can be 
detected by fluorescence, it is beneficial to confirm reporter protein expression by visualization of 
proteins by electrophoretic and Western blot membrane development methods.  These methods 
were employed for additional confirmation of achieving unnatural amino acid incorporation via 
the present invention. 
Results and methods for constructing a two plasmid system for successful incorporation 
of unnatural amino acids into P. syringae pv. tomato DC3000 are provided in this thesis. 
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Chapter 2.  Investigation of Promoters for Transcription of Exogenous tRNA and tRNA 
Synthetase in Pseudomonas syringae pv. tomato DC3000. 
2.1 Identifying a Native P. syringae DC3000 Promoter for Exogenous tRNA 
 Incorporation of unnatural amino acids into living species requires the addition of an 
exogenous tRNA and corresponding synthetase that have a high affinity for the amino acid to be 
incorporated but have little or no affinity to natural amino acids.  This selectivity is first acquired 
by modification of the tRNA and synthetase structures by site-directed mutagenesis and evolution 
of these molecular species during growth assays in presence of the unnatural amino acid.     
However, fine-tuning the tRNA and synthetase is only useful insofar as the molecules can 
be used within the species of study.  Effective expression of these components in vivo is required 
to install unnatural amino acids into proteins of study and for all these processes there must be 
promotion of the tRNA and synthetase transcripts (1) at an effective rate to meet the demands of 
the ribosomal machinery synthesizing the nascent peptide chain for any proteins of study, (2) at a 
level low enough to not create toxic results from these exogenous molecules, (3) as a stable form 
of tRNA or synthetase that can exist long enough within the cell to allow for the first case, above.  
Case (2) is especially important if during the selection and evolution process the tRNA or 
synthetase still interact with endogenous protein translation machinery.  Finally, there must be a 
method for observing the efficacy of tRNA and synthetase production and activity, i.e. Northern 
blot, protein-based electrophoresis, or reporter protein.   
To enable incorporation of unnatural amino acids into P. syringae DC3000 by use of 
exogenous tRNA, the host organism must promote transcription of the tRNA for expression 
without degradation of the gene product before it is cleaved to maturity.  Therefore, this project 
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required designing a tRNA gene cassette having 5’ and 3’ regions naturally found in P. syringae 
DC3000. 
One promoter sequence expected to be effective in P. syringae DC3000 is that for tRNA 
genes.  Initiator tRNA (Met) promoters are shown to yield high transcript products for pathogenic 
bacteria, such as Mycobacterium tuberculosis (Vasanthakrishna, 1997) and such promoters have 
been used to express exogenous tRNA in that same species (Wang, 2010).  Although, P. syringae 
DC3000 is not an animal pathogen, it can be assumed that native initiator tRNA promoter and 
terminal regions would be similarly effective for this plant pathogen.  Because stable RNA in vivo 
require (a) a consensus upstream sequence that is regulated to produce an appropriate supply of 
transcript and (b) the downstream poly(A) tail to provide for recognizable precursor-tRNA that 
can be processed into the active unit, the expression of an exogenous tRNA within P. syringae 
DC3000 should be successful when using the 5’ and 3’ regions from native tRNA genes.  In 
addition, control studies in E. coli using P. syringae DC3000 5’ and 3’ regions of the initiator 
tRNA are expected to yield functional products, although likely at a lower level than for the 
native organism. 
Using the E. coli gene metY as the proto-type for an initiator tRNA in DC3000, 
nucleotide BLAST of the E. coli DH1 methionyl-tRNA, metY (NC_017638.1), against the 
DC3000 genome showed a 93% identity with tRNA-met-5 (NC_004578.1).  It was expected that 
the native 5’ and 3’ flanking regions would be sufficient for transcription and processing of any 
exogenous tRNA.  However, as is shown in Figure 7, the met-5 initiator tRNA appears 
downstream to tRNA-leucyl-4, making possible difficulty ensuring the promoter region could be 
easily amplified via PCR without contamination of unwanted DNA.  Therefore, the flanking 
regions of another methionyl-tRNA, tRNA-met-3, from P. syringae DC3000 was chosen (Jiantao 
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Guo, UNL) for amplification and tRNA cassette construction.  This process was performed using 
PCR was used to amplify the 5’ and 3’ regions of P. syringae DC3000 tRNA-met-3 from genomic 
DNA and these regions were used to flank the M. barkeri Pyl-tRNA gene via overlapping PCR.  
This tRNA cassette was then inserted into the vector containing the GFPuv reporter protein 
sequence.   
 
Figure 6:  Nucleotide BLAST showing 93% homology between E. coli DH1 (Subject) and P. 
syringae DC3000 (Query); (http://www.ncbi.nlm.nih.gov/)   
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Figure 7:  Reference location of P. syringae DC3000 tRNA-Met-5 within genetic region as found 
within NCBI information site.  Image shows leucyl-tRNA upstream in same locus and so tRNA-
met-5 was later substituted for tRNA-met-3.  
  
Figure 8:  Reference location of P. syringae DC3000 tRNA-Met-3 within the genetic region as 
found within NCBI information site. 
2.2 Developing tRNA, GFPuv and Synthetase Plasmids for Testing tRNA Promotion 
Plasmids containing the GFPuv reporter protein as wild-type or N149TAG mutant were 
prepared and, for mutant GFPuv, the Pyl-tRNA gene cassette featuring P. syringae DC3000 
tRNA-met-3 promoter region was prepared.  The tRNA-met-3 terminator region provided 
difficulty in cassette design and so the Pyl-tRNA, upon initial amplification from house vector, 
was amplified with a designed poly(A) tail to allow for proper in vivo processing.  It was not 
observed that strains featuring only the mutant GFPuv N149TAG and any suppressor tRNA give 
fluorescence results to suggest DC3000 houses TAG stop codon suppressor machinery.  This 
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result is not surprising given the low frequency of TAG in the P. syringae DC3000 genome, as 
shown in Table 1, below (Nakamura, 2000).  Indeed, it was not expected that any TAG 
suppression native to DC3000 would cause significant false positive results in studies involving 
biological probes or crosslinking amino acids, as strains induced with the necessary UAA at 1.0 
mM or greater concentrations should promote higher UAA-incorporated mutant proteins rather 
than natural amino acid positioning in the TAG stop codon site.   
The following results are organized to reflect the methods in Chapter 4.  Plasmid 
construct images are shown, followed by initial cell-based fluorescence assays for strains 
featuring that construct.     
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Table 1: Codon analysis frequency in P. syringae pv. tomato DC3000.  Stop codon frequency is 
highlighted by red border in upper right-hand corner of table. {Nakamura, 2000 ; retrieved 
directly from: http://www.kazusa.or.jp/codon/cgi-bin/showcodon.cgi?species=223283 (June 6, 
2014)} 
2.2.1 pBBR1MCS3-GPFuv N149TAG and pBBR1MCS3-GFPuv WT 
Reporter protein plasmids were constructed and tested for fluorescence in E. coli 
Genehog, E. coli NEB5α, and DC3000, as single transformants or in presence of exogenous 
synthetase.  Fluorescence data is shown in subsequent sections.   
 
Figure 9:  Plated Genehog cells for ligation product from pBBR1MCS (v-only; left) with 
GFPuvN149TAG cassette insert (v+i; right).  Results are similar for GFPuv WT ligation. 
 
 
v                       v+i 
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2.2.2 pBBR1MCS3-GFPuv N149TAG-Mb. Pyl-tRNA (pSR6.067) 
Use of pBBR1MCS3-GFPuv N149TAG for construction of pSR6.067 containing the Pyl-
tRNA allowed for transformation of Genehog and DC3000 wild-type cells.  Cells were inoculated 
to liquid culture and grown in their optimal environments, induced, and later analyzed for 
fluorescence of cells pellets or culture liquid supernatant. 
 
Figure 10:  Genehog cells on LB/Tet
10
 agar plates for pSR6.067 ligation product.  (Abbrev.: v, 
vector only control; v+i, vector + Pyl-tRNA insert.) 
2.2.3 pML123-tac-PylRS WT 
Construction of the synthetase-containing vector involved several steps, including an 
intermediate plasmid to create a promoter cassette featuring the tac promoter, as vector, pML123 
contains the strongly-promoting neomycin promoter and as the tac promoter is useful in both E. 
coli and P. syringae (Labes, 1990), using this latter promoter offered a good positive control 
during plasmid development in both strains.  Vector was co-transformed into Genehog and 
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DC3000 cells along with either pBBR1MCS-GFPuvN149TAG only, or pSR6.067 (Pyl-tRNA, 
GFPuvN149TAG).  Co-transformed cells were analyzed for fluorescence of cell pellets and liquid 
culture suspensions. 
 Transformation of DC3000 (DC), by electroporation or Genehog cells (G), by heat shock, 
with pSR6.067 was successful and subsequent transformation of DC:pSR6.067 with pML123-
PylRS (electroporation) or G:pSR6.067 chemical competent cells with pML123-PylRS allowed 
for inoculation into liquid media and induction of Pyl-tRNA/RS machinery with 0.3 mM IPTG 
and 5 mM Boc-lysine.   
 Fluorescence experiments (Table 2; Graph 1) show fluorescence only for induced 
Genehog cells (OD600 0.05) with added boc-lysine (5 mM).  Repeated attempts at incubating 
induced DC3000 cells at room temperature (RT) or 30 
o
C did not result in fluorescence. 
 Nevertheless, it was apparent the Pyl-tRNA gene cassette featuring the DC3000 promoter 
region functioned properly, as shown by the high fluorescence in Genehog cells under induction 
with Boc-lysine added.  With this noted success of the tRNA cassette functionality, efforts turned 
to investigate the exogenous synthetase activity in P. syringae DC3000 -- by substituting with 
mutant synthetase (PylRS Y348F and PylRS
NAA
) and altering promoter regions in the pML123 
vector from tac to T5.   
OD600 ODfluor RFU Dev. Reported +/-
4.00 0.05 -11.125 37.76029 -11.1 37.8
13.2 0.05 2710 84.59314 2710 84.6
13.5 0.05 5698.333 16.19671 5700 16.2
4.20 0.05 79 84.59314 79.0 84.6
4.70 0.05 35.66667 16.19671 35.7 16.2
1.40 0.05 700 255.9727 700 256
1.40 0.05 379.3333 77.51344 380 77.5
1.60 0.05 5417 323.9182 5420 324
DC:GFPuv WT non
DC3000 WT
Strain:Plasmid
G:6.067+Ptac.PylRS WT ind +
G:6.067+Ptac.PylRS WT ind -
G:6.067+Ptac.PylRS WT non
DC:6.067 ind -
DC:6.067 non
DC:GFPuv WT ind -
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Table 2:  Single trial test for fluorescence of GFPuv (WT or N149TAG) in DC3000 or Genehog 
cells with all samples incubated for 19 hours and densities normalized to OD600 0.05 for analysis.  
For ease of comparison, “Reported RFU +/- RFU” shown in right-hand columns.  DC3000 WT, 
wild-type strain DC3000; DC3000:pBBR-GFPuv WT non-induced (non) and 0.3 mM IPTG 
induced (ind-) DC3000 transformed with pSR6.067 (listed as DC:6.067); G:6.067+Ptac.PylRS 
WT, Genehog transformed with pSR6.067 and pML123.tac.PylRS WT feat. non, ind-, and IPTG + 
5 mM boc-lysine (ind+). 
 
 
Graph 1:  Counterpart for Table 1, showing relative fluorescence of cells for DC3000 wild-type 
(blank), and DC3000, Genehog transformed strains as non-induced (non), IPTG induced (ind-) 
and IPTG + 5 mM boc-lysine (ind+).  (Abbrev. as DC, DC3000; GFPuv WT, pBBR1MCS3-
GPFuv WT; 6.067, pSR6.067; G, Genehog; Ptac.PylRS WT, pML123.tac.PylRS WT.  Error bars 
reflect consistency being multiple measurements for same samples to denote precision of 
scanning with SynergyH1 reader). 
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OD600 ODfluor RFU
4.0 0.05 666
5.7 0.05 353
5.8 0.05 448
4.9 0.05 263
Strain:Plasmid
DC:6.067:Ptac.PylRS WT ind+
DC:6.067:Ptac.PylRS WT ind-
DC:6.067:Ptac.PylRS WT non
DC3000 WT 
 
Table 3:  Single trial fluorescence of DC3000 with pSR6.067, pML123.tac.PylRS WT in 
comparison to DC3000 wild-type (WT) cells.  Abbrev. DC, DC3000; 6.067, pSR6.067; 
Ptac.PylRS WT, pML123.tac.PylRS WT; non, non-induced; ind-, IPTG induced; ind+, IPTG 
induced + boc-lysine.  Single scan for suspensions normalized to 0.05 OD600.  DC3000 WT 
considered as blank; correction not done to show positive RFU values. 
2.3.1 Analysis of DC3000:pSR6.067 featuring pML123-tac.PylRS Y348F 
PCR amplification of PylRS Y348F from pBK vector resulted in digestible product that 
was prepared as for PylRS WT to produce   
ODfluor RFU RFU/OD
N/A 0 0
0.1 37.5 375
0.1 1329.5 13295
0.1 -10 N/A
0.1 -1.5 N/A
0.1 40 400
Sample
DC:6.067 only
DC:6.067:YF ind
DC:6.067:YF non
G:6.067:YF ind
G:6.067:YF non
Blank
 
Table 4:  Initial test for GFPuv mutants from Genehog (G) or DC3000 (DC) cells containing 
pSR6.067 (6.067) and pML123.tac-PylRS Y348F (YF).  PBS blank, non-induced (non) and 
induced (ind) with IPTG and 5 mM boc-lysine. 
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ODfluor RFU RFU/OD Reported ODfluor RFU RFU/OD Reported
N/A 0 N/A 0 N/A 0 N/A 0
1.1375 682.5 600.0 600.0 1.1285 2888.5 2559.592 2559.6
1.074 692.5 644.7858 644.8 0.99 2812.5 2840.909 2800
0.8315 694 834.6362 835 0.9385 1530.5 1630.794 1630.8
1.106 723 653.7071 654 1.093 2715.5 2484.446 2485
0.758 1442 1902.375 1900. 0.759 1695.5 2233.86 2234
ODfluor RFU RFU/OD Reported ODfluor RFU RFU/OD Reported
N/A 0 N/A 0 0 N/A 0
0.9555 10231.5 10708.01 10710 0.767 9078.5 11836.38 11800
0.866 6190 7147.806 7150 0.552 4426.5 8019.022 8020
0.7735 4332 5600.517 5600. 0.6795 4839.5 7122.149 7122
0.9255 7633 8247.434 8247.4 0.852 7565 8879.108 8880
0.62 3164.5 5104.032 5100 0.5555 3314.5 5966.697 5966.7
DC:6.067
6.067,WT non
6.067, WT ind+
6.067, YF non
6.067, YF ind+
48 hrs. PI36 hrs. PI
Blank
DC:6.067
12 hrs. PI
Sample
Blank
24 hrs. PI
Sample
6.067, YF ind+
6.067, YF non
6.067, WT ind+
6.067,WT non
 
Table 5:  RFU/OD values for 48-hour time course of non-induced (non) and induced (IPTG and 
boc-lysine; ind+) DC3000 cells containing pSR6.067 (6.067) with pML123.tac-PylRS (WT or 
Y348F).  Abbrev: P.I., hours post induction; WT, pML123.tac.PylRS WT; YF, pML123.tac.PylRS 
Y348F; DC:6.067 (DC3000:pSR6.067 only). 
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Graph 2:  RFU/OD values for samples shown in Table 5. No strains featured higher fluorescence 
than Pyl-tRNA, GFPuv n149TAG, suggesting the synthetase promoter was at fault Abbrev. 6.067, 
pSR6.067; WT, pML123.tac.PylRS WT; YF, pML123.tac.PylRS Y348F.  . 
A useful method for detecting successful of the dual plasmid system requires  
reproducible fluorescence increase over non-induced (non) cells for those samples induced with 
both IPTG and the unnatural amino acid (ind+).  These “ind +” cell pellets should also always 
show higher fluorescence than IPTG-only induced (ind –) pellets.  There was no attempt at 
analyzing fluorescent of pellets for DC3000:pBBR1MCS3 strain; the wild-type DC3000 and 
transformed strains featuring reporter proteins were suitable controls for this project.    
Cell-based fluorescence assay for DC3000:6.067:PylRS (WT, Y348F) showed the 
pyrrolysine tRNA/RS system worked well in E. coli, but it was considered to change the 
synthetase promoter from tac to T5 to better understand lack of success in DC3000.  After 
changing promoters, values of fluorescence dependent on adding boc-lysine to the culture 
significantly increased over non-induced cultures.  However, analysis of samples induced with 
IPTG only also produced significantly high fluorescence.  Because of this, it appeared that either 
the Pyl-tRNA or the PylRS was interacting with DC3000 native translational machinery.   
After the wild-type PylRS did not show the expected high fluorescence in DC3000, it 
was decided to construct the synthetase vector for the DC3000 system using the Tyr348Phe 
pyrrolysine synthetase mutant (PylRS Y348F), with intent that the mutant would provide brighter 
fluorescence for the GFPuv reporter in induced strains due to higher affinity for the Boc-lysine 
amino acid (Yanagisawa, 2008). 
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 Initial test of GFPuv mutants from Genehog and DC3000 featuring pSR6.067 and 
pML123.tac.PyRS Y368F are shown in Table 2.  Incidentally, Genehog-expressed GFPuv N149-
boc-lysine fluorescence was not as intense as expected and a second test was run for induced 
DC3000 cells harboring either the PylRS Y368F mutant or a second pML123.tac.PylRS WT 
(PylRS #2) plasmid, but results for DC3000 were similar (data not shown). 
2.3.2 pML123-tac-PylRS NAA Mutant 
The Pyl-tRNA/RS system within E. coli Genehog cells gave expected increased 
fluorescence for cultures induced and charged with Boc-lysine, but this trend was not observed in 
P. syringae DC3000.  Considerations for this inconsistency included (a) a mutation in tac, RBS, 
or PylRS DNA sequence in the pML123 plasmid, (b) inability for DC3000 to take up/use Boc-
lysine, or (c) poor efficiency of tac promoter for synthetase production in DC3000.   
To examine the first possibility, sequencing of the pML123-PylRS vector with primers to 
recognize tac promoter site.  Results showed no mutation in the promoter, RBS sites, or the 
upstream sequence for PylRS.   
To examine if DC3000 had trouble importing or utilizing Boc-lysine, we attempted to use 
a library of PylRS variants prepared in our lab (Tong Ju, University of Nebraska-Lincoln) to 
select for a synthetase that could recognize natural amino acids (NAA).  Use of a PylRS
NAA
 
would still allow for interaction with the Pyl-tRNA but charge the tRNA with natural amino acids 
to produce a full-length and fluorescing GFPuv N149-NAA protein.   
This selection process required the use of E. coli cells containing the pREP-PylT plasmid 
(Neumann, 2008) featuring a T7 RNA polymerase and a chloramphenicol acetyltransferase 
(CAT) that both possess TAG stop codons within the peptide sequence -- two stop codons in the 
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polymerase, one in the resistance protein -- as well as the suppressor Mb. Pyl-tRNA
CUA
 for PylRS 
interaction.  Properly suppressed TAG codons allow for full-length synthesis of the polymerase 
which will recognize the plasmid-based T7 promoter region preceding the plasmid’s wild-type 
GFPuv reporter protein.  Expression of full-length CAT from the plasmid yields chloramphenicol 
resistance with increasing TAG suppression due to effective synthetase charging of natural amino 
acids to the suppressor tRNA. 
The following results feature plated cells related to the evolution of PylRS Y348F 
synthetase with increased selectivity for natural amino acids (PylRS
NAA
). 
   
Figure 11:  BL-5 library plates for 10
5 
and 10
7 
cells prepared from glycerol stock.  Two colonies 
from the 10
7 
plate were chosen for purify PylRS
NAA
, a synthetase to recognize natural amino 
acids. 
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Figure 12a:  Plated E. coli pREP-PylT cells (see below) for transformants prepared from plasmids 
purified from initial BL-5 plating. 
   
Figure 12b:  Transformed Genehog cells from ligation of digested pJF118EH-mod1 (v-only; left) 
and digested PylRS
NAA
 insert (v+i; right). 
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Figure 13:  DNA gel for Genehog plated cells from ligation of digested pML123 (v-only; left) and 
PylRS
NAA
 insert (v+i; right).  Ligation efficiency for v:v+i was 6:15 colony forming units. 
As shown in Figure 11, a single-round selection yielded viable colonies in presence of 
chloramphenicol (50 µg/mL), but recombination, transformation, and growth under IPTG 
produced no significant GFPuvN149-NAA fluorescence in DC3000 cells (data not shown).  
Therefore, it was decided that the synthetase promoter should be switched from tac to the same 
T5 promoter cassette as used with the GFPuv reporter proteins. 
As a final note on use of Boc-lysine in DC3000, there has been little research into the 
effective uptake of unnatural amino acids into P. syringae and different bacterial species are 
likely to have subtle differences in their specific amino acid import/transport machinery.  A 
survey of the KEGG database shows such differences between DC3000 (left) and E. coli DH10B 
(right) strains as shown in Figure 14.  The ArgT protein (red border; left column; white box) may 
be tantamount for uptake of Boc-lysine in DC3000, for example, given its categorized role in 
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transport of lysine, arginine, and ornithine – all polyamine amino acids.  However, other 
transporter proteins (e.g. HisM) may be suspect to recognition of Boc-lysine, in this case. 
A supplemental study of any unnatural amino acid uptake in DC3000, would involve 
addition of the amino acid to mid-log phase DC3000 cells in culture media followed by collecting 
of supernatant over given time-points for analysis by LC-MS/MS.  This method could be easily 
complemented by introduction of exogenous or overexpressed native transporter proteins into the 
host, followed by growth under similar conditions for analysis.  To note, however, in the event an 
organism of study does not need or cannot use the amino acid, there is always a chance of 
excretion of the molecule back into the supernatant.  In the case of Boc-lysine, if effective uptake 
was accompanied by ineffective use, the amino acid could be expected to be released back into 
the environment in total or degraded for recycling of useable functional groups and waste release. 
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Figure 14:  Comparison of phosphate and amino acid transporters between P. syringae pv tomato 
DC3000 (left) and E. coli DH10B (right).  Blocks highlighted in green are known pathway nodes 
found in that organism.  For link to the P. syringae pv. tomato DC3000 KEGG site:  
{http://www.genome.jp/kegg-bin/show_pathway?pst02010} 
2.4 pBBR1MCS3.T5-PylRS WT, pML123.T5-PylRS WT, and pML123.T5-PylRS Y348F 
To enhance expression of the synthetase, PylRS (WT or Y34F), an alternative promoter 
was selected.  It was seen that the GFPuv WT was well expressed in both E. coli and DC3000 
cells, so it was decided to use the T5 promoter and ribosome binding site (RBS) for increasing 
29 
 
 
synthetase production.  As the T5.RBS.GFPuv WT (or N149TAG) cassette was initially cut from 
a pLei-based vector, substitution of the reporter protein for either synthetase allowed for direct 
insertion of T5.RBS.PylRS (WT or Y348F) from pLei vector into plasmids pML123 and also 
pBBR1MCS3.  Vector pBBR1MCS3 had shown successful expression (as per fluorescence) of 
GFPuv WT from DC3000 so this construct was created for possible troubleshooting of synthetase 
expression.  That is, if there had been a problem with the new pML123.T5 constructs, the 
pBBR1MCS3.T5 series would have served as an additional experimental control. 
Shown below in Figures 15, 16 are the plates for E. coli cells transformed with ligation 
products at first and second stages of experimental design.  Fluorescence results are shown in 
Table 6. 
 
Figure 15:  Plated Genehog cells for ligation of pET28a (v-only; left) with PylRS WT insert (v + 
i; right).  Plates for PylRS Y348F were similar; vector sample used was same for both. 
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Figure 16:  Plated Genehog cells for ligation of pML123 (v-only; left) with PylRS Y348F insert (v 
+ i; right).  Plates for PylRS WT ligation and transformation utilized same vector sample. 
RFU ODfluor RFU/OD Reported RFU ODfluor RFU/OD Reported
0 N/A N/A 0 0 N/A 0 0
670. N/A N/A 670. 670. N/A N/A 670.
1218.75 0.569 2141.916 2140 N/D N/A N/D N/A
1092.50 0.246 4441.057 4440 1773.25 0.297 5970.539 5970
1159.75 0.174 6665.23 6670 4251.75 0.327 13002.29 13000
829.50 0.332 2498.494 2500 4292.75 0.506 8483.696 8480
1041.00 0.069 15086.96 15100 1460.75 0.05 29215 29200
1486.25 0.119 12489.5 12500 906.50 0.039 23243.59 23200
5472.00 0.298 18362.42 18400 2872.00 0.236 12169.49 12200
43 hrs. 30 oC, 16 hrs. 4 oC20 hrs. 30 oC, 16 hrs. 4 oC
6.067:PylRS YF ind+
KB-T/Tet10
DC WT
Blank
Sample
6.067:PylRS YF ind-
6.067:PylRS YF non
6.067:PylRS WT ind+
6.067:PylRS WT non
6.067:PylRS WT ind-
 
Table 6:  Comparison of DC3000 cells featuring pSR6.067 (6.067) in presence of either 
pML.T5.RBS.PylRS WT (PylRS WT) or pML.T5.RBS.PylRS Y348F (PylRS YF).  20-hour and 
43-hour time-points were grown post-induction (0.5 mM IPTG; 5 mM boc-lysine) at 30 
o
C, 250 
rpm and then set into 4 
o
C for 16 hours.  Results of induction with amino acid (ind+) against 
induction without amino acid (ind-) showed that over 43-hour period, fluorescence of (ind+) was 
lower than that for (ind-).  These unexpected results suggest the host strain translation machinery 
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may be working with plasmid-based machinery to incorporate natural amino acids into TAG 
location of GFPuv N149 reporter protein. 
 Substitution of the synthetase promoter to the T5 promoter cassette gave increased 
fluorescence of the GFPuv reporter protein, but it was realized that a significant increase over 
non-induced cultures was apparent (Table 6) without the addition of boc-lysine unnatural amino 
acid.  These results are not the expected non < ind- < ind+ RFU/OD for transformed P. syringae 
DC3000 cultures and, therefore, it was decided that this Pyl-tRNA/RS system would not be 
suitable for selectively producing mutant proteins in future experiments.  There was no further 
attempt to understanding the interactions of exogenous tRNA or synthetase.  An alternative 
tRNA/RS pair, from Methanocaldococcus jannaschii, was next studied. 
 For further analysis, however, it was decided to attempt purification of any full-length 
GFPuvN149 mutants that may be produced within DC3000 cells under induction alongside Boc-
lysine.  Purifications and electrophoretic analyses were performed in concert with P. syringae 
DC3000 cultures featuring the M. jannaschii tRNA/RS dual plasmid system; results are therefore 
shown in Chapter 3. 
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Chapter 3:  Construction and Use of Dual Plasmid System Featuring M. jannaschii Tyrosyl-
tRNA
CUA
 and pML123.T5. Mj. BpFRS (pSR8.010, pSR8.017) 
 A different tRNA/RS pair was introduced into P. syringae pv. tomato DC3000 from the 
Archaea,  Methanocaldococcus  jannaschii.  The tRNA anticodon arm has been modified to 
recognize the TAG stop codon; the corresponding synthetase for this Tyr-tRNA
CUA 
has been 
evolved in separate experiments to select for specific unnatural amino acids.  Different synthetase 
proteins, including the wild-type TyrRS and the evolved species, BpFRS and AzFRS that specific 
for the crosslinking amino acids, BpF and AzF, resp., were studied in presence of the tRNA to 
effect full-length translation of the GFPuv reporter protein featuring UAA at position N149TAG.  
The full-length GFPuvN149-UAA mutant produces fluorescence when properly folded and also 
contains a C-terminal 6xHis tag to allow for purification by nickel affinity column. 
3.1 Construction of Vector, pSR8.010, Containing M. jannaschii tRNA and GFPuvN149TAG 
The vector containing the GFPuvN149TAG reporter protein, pBBR1MCS3-GFPuv 
N149TAG, was modified to include the M. jannaschii Tyr-tRNA
CUA
 gene cassette featuring the 
P. syringae DC3000 tRNA-met-3 promoter region and the poly(A) tail as in Chapter 2.  Analyses 
of fluorescence in DC3000:pSR8.010 (8.010) as non-induced or IPTG-induced against wild-type 
DC3000 culture were performed against DC3000 wild-type cells at 2-days (Table 7), and 5 days 
(Table 8) against DC:6.067 (Pyl-tRNA).  In this experiment IPTG induction serves only to give 
expression of the GFPuvN149TAG truncated protein.  In all cases, there was a level of 
background fluorescence for the induced cells.  As shown in Table 9, the fluorescence for 
DC:8.010 cells (1460 RFU/OD) was higher than for DC:6.067 (513 RFU/OD) under IPTG 
induction, suggesting that either the M. jannaschii tRNA was more stable, more highly expressed, 
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or better at supplying natural amino acids to the TAG codon site than the M. barkeri tRNA.  
Nevertheless, because the GFPuvN149-based fluorescence was generally lower under IPTG-
induction (Table 7), and fluorescence measurements for DC3000 cells featuring only the 
GFPuvN149TAG construct (Table 9; GFP non, ind) were also higher than wild-type DC3000 
cells, it was decided to pursue studies involving vector pSR8.010 in presence of the synthetase 
proteins. 
RFU Dev. RFU/OD Dev. Reported Dev.
-0.052593 0.152029 -- -- -0.05 0.15
-- -- 478.2639 37.97862 478 38
-- -- 2045.848 453.1645 2050 453
-- -- 1839.58 437.5054 1840 438DC:pSR8.010 ind-
DC:pSR8.010 non
DC WT
Sample
Blank
 
Table 7:  Average of three trials for cell fluorescence of DC3000:pSR8.010, featuring the M. 
jannaschii Tyr-tRNA
CUA
, GFPuv N149TAG.  Cells were incubated 44-48 hours P.I. with 0.5 mM 
IPTG working concentration (ind-) or no IPTG (non), followed by 20 hours incubation at 4 
o
C.  
Wild-type DC3000 is shown as reference; OD600 values used for calculating RFU/OD were 
between 0.1 and 1.2, as measured by 10x dilution of cell suspension prior to dilution for assay.   
OD (final) RFU Dev. RFU/OD Reported
PBS N/A 0.333333 53.850 N/A 0.333
WT 1.10 1019 13.697 926.3636 926
8.010 non 1.00 2870.5 37.217 2870.5 2870
8.010 ind- 1.10 2556 37.202 2323.636 2320
DC3000 pSR8.010 120/18 Samples (120 hrs 30 oC, 18 hrs 4 oC)
 
Table 8:  Single trial fluorescence test of 120-hour P.I.  DC3000:pSR8.010 (8.010) after induction 
of mid-log cultures with 0.5 mM IPTG (ind-), incubation at 30 
o
C, 250 rpm, followed by 18 hours 
at 4 
o
C.  OD600 values were obtained at 10x dilution of culture sample and back-calculated for 
RFU/OD results.  DC3000 wild-type (WT) is shown for comparison. 
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Sample OD600 RFU Dev. RFU/OD Reported
Blank N/A 0 12.910 N/A 0
WT 7.10 5615.333 36.501 790.892 791
GFP non 11.50 11144 67.735 969.0435 969
GFP ind 12.60 14684 199.610 1165.397 1170
8.010 non 5.30 6241 75.974 1177.547 1180
8.010 ind 7.20 10516.33 141.924 1460.602 1460
6.067 non 24.40 23759.33 299.604 973.7432 974
6.067 ind 26.00 13344.67 190.768 513.2564 513  
Table 9:  Single trial fluorescence test for DC3000 containing pBBR1MCS3-GFPuv N149TAG 
only (GFP), pSR8.010 (8.010), or pSR6.067 (6.067) against wild-type (WT) strain.  Sample 
OD600 values were obtained at 10x culture suspension and then back-calculated for RFU/OD 
results.  Deviation (Dev.) in emission results are for triplicates of same sample in microplate wells 
or quadruplet for PBS blank.  Samples were either induced (ind-) with 0.5 mM IPTG or non-
induced (non). 
3.2 DC3000:pSR8.017; Analysis of DC3000 Harboring pSR8.010 and pSR8.017 Plasmids 
Plasmid pSR8.017 was designed using the T5 promoter region for expression of M. 
jannaschii tyrosyl-synthetase evolved to charge BpF onto the cognate tRNA
CUA
.  Plasmid 
pSR8.017 (pML123.T5.BpFRS) then used to co-transform DC3000:pSR8.010 for growth in 
liquid media in presence of IPTG +/- 0.1 mM BpF for fluorescence analysis (Table 11).  
 Induction under influence of BpF produced higher fluorescence (ind+; 2620 RFU/OD) 
than without BpF (ind-; 2020 RFU/OD) or non-induced cells (non; 1840 RFU/OD).  This 
experiment shows the two plasmid system works as expected for the M. jannaschii Tyr-
tRNA
CUA
/BpFRS pair in P. syringae DC3000 and full-length GFPuvN149-BpF was later purified 
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by affinity chromatography and fractions were analyzed by SDS-PAGE and Western blot 
(Figures 26, 27, respectively).   
 
Figure 17:  Genehog cells featuring ligation product for pML123 (v-only; left) and BpFRS insert 
(v+i; right) to show efficiency of DNA recombination reaction.  Cells were plated to KB-T/Gen
10 
agar plates. 
RFU Dev. RFU/OD Dev. Reported Dev.
-0.02333 0.202704 -- -- -0.05 0.15
-- -- 469.8958 49.64479 470. 49.7
-- -- 468.0476 21.28055 468 21.3
-- -- 427.9028 100.5467 428 101
Sample
Blank
DC WT
DC:pSR8.017 non
DC:pSR8.017 ind-  
Table 10:  Average of duplicate trials for cell fluorescence of DC3000:pSR8.017 (BpFRS-only) 
induced with 0.5 mM IPTG (ind-) or non-induced (non) to show strains maintain native 
fluorescence.  Samples were analyzed in concert with wild-type DC3000 strain (DC WT).   
RFU Dev. RFU/OD Dev. Reported Dev.
Blank Blank -0.04667 0.143965 -- -- -0.05 0.14
WT WT -- -- 568.2639 173.9573 568 174
8+8 non 8+8 non -- -- 1844.667 638.193 1840 638
8+8 ind- 8+8 ind- -- -- 2020.419 618.8777 2020 619
8+8 ind+ 8+8 ind+ -- -- 2617.432 546.4868 2620 547
Sample
 
36 
 
 
Table 11:  Average of fluorescence data for three trials for DC3000:pSR8.010:pSR8.017 (8+8).  
All cells were induced with 0.5 mM IPTG, where applicable, and with 1 mM BpF (ind+) or 
without (ind-) or non-induced (non).  Cell cultures were grown for 44-48 hours post-induction.  
Cell densities were either between 0.8 and 1.2 OD600 or normalized to OD600 0.1 for analysis.   
Because DC3000 transformants featuring BpF-specific synthetase (BpFRS) exhibited 
higher fluorescence of cultures induced with both IPTG and 1 mM BpF (ind+) over IPTG-only 
induced (ind-) and non-induced (non) cultures (Table 11), additional confirmation was obtained 
by the induction and growth of 28 mL DC3000:pSR8.010:pSR8.017 cultures for 48 hours at 30 
o
C, 250 rpm and subsequent purification of full-length GFPuv N149BpF mutant protein.  These 
results are shown in SDS-PAGE (Figure 23) and Western blot detection images (Figure 24). 
3.3.1 pML123.T5-TyrRS WT (pSR8.037) and pML123.T5-AzFRS (pSR8.044) 
 Further investigation into the capability of this dual plasmid system included growth of 
DC3000:pSR8.010 strain subsequently transformed with plasmids containing M. jannaschii 
wild-type Tyr-RS (pSR8.037) or the evolved synthetase, AzFRS (pSR8.044), which recognizes 
the p-azido-phenylalanine crosslinking amino acid.   
 Constructs were prepared from in-house plasmids as above for the BpFRS and 
transformation into P. syringae DC3000 and E. coli Genehog cells yielded viable colonies for 
liquid culture growth at 36 or 48 hours.  Results shown in the following tables include initial 
fluorescence measurements of 36-hour cultures of DC3000 with tRNA and wild-type TyrRS 
(Table 12), multiple-trial experiments to compare fluorescence for TyrRS and AzFRS in 36-hour 
cultures of DC3000 (Table 13), and 48-hour DC3000 cultures expressing AzFRS alongside tRNA 
(Table 14).  Complimentary fluorescent studies were done in E. coli Genehog cells transformed 
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with tRNA and BpFRS or AzFRS to compare effectiveness of the two evolved synthetase 
proteins (Table 15). 
RFU Dev. OD RFU/OD Reported
PBS -0.11111111 7.149204 N/A N/A N/A
DC WT 42.6666667 11.0227 0.10 426.67 427
TyrRS non 175.222222 11.3002 0.10 1752.22 1750
Tyr - 268.166667 13.80459 0.10 2681.67 2680
DC3000 36/48 Samples (36 hrs 30 oC; 48 hrs 4 oC)
 
Table 12:  Single trial fluorescence readings for DC3000 cell pellets featuring pSR8.010 and 
pSR8.037 as non-induced (TyrRS non) and IPTG-induced (Tyr-) over 36-hour period.  Deviation 
(Dev.) is shown for multiple analysis of same culture sample in microplate wells.  As samples 
were normalized to OD600 = 0.1 for analysis. 
 
RFU Dev. RFU/OD Dev. Reported Dev.
0 0.111111 -- -- 0 0.11
-- -- 508.8889 252.1317 509 252
-- -- 2697.407 25.10062 2700 25.1
-- -- 2304.074 423.2915 2300 423
-- -- 2294.815 253.4024 2290 253
-- -- 2345.185 364.2027 2350 364
-- -- 1760.37 176.192 1760 176
Blank
AzF ind +
AzF ind -
AzF non
Tyr non
Tyr ind -
DC WT
Sample
 
Table 13:  Average of fluorescence readings over three trials for DC3000:pSR8.010:pSR8.044 
(AzFRS) cultured over 36 hours P.I. in concert with DC3000 wild-type (DC WT), as well as 
DC3000:pSR8.010:pSR8.037 (Tyr).  Cultures for transformed strains were either non-induced 
(non), IPTG induced (ind-) or induced by IPTG and 1 mM AzF (ind+). 
Sample OD600 ODfluor RFU Dev. RFU/OD Reported
Blank N/A N/A 0 7.483 N/A 0
DC 48 4.40 0.10 76.500 12.951 765 765
010+AzF 48 n 1.50 0.10 271.917 28.468 2719.167 2720
010+AzF 48 - 2.30 0.10 233.917 11.859 2339.167 2340
010+AzF 48 + 1.60 0.10 192.917 13.201 1929.167 1930  
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Table 14:  Single trial fluorescence reading for DC3000:pSR8.010:pSR8.044 (010+AzFRS) 
cultured over 48 hours P.I. in concert with DC3000 WT.  Cells cultures were either non-induced 
(n), IPTG induced (-) or induced by IPTG and 1 mM AzF (+).  Deviation (Dev.) is shown for 
multiple analysis of same culture sample in microplate wells. 
RFU Dev. OD RFU/OD Reported
0.111 26.770 N/A N/A N/A
36.556 7.468 0.10 365.556 370
39.222 15.619 0.10 392.222 390
68.444 8.904 0.10 684.444 680
65.000 37.620 0.10 650.000 650
41.222 17.563 0.10 412.222 410
117.444 25.006 0.10 1174.444 1200
BpF non
Genehog 8+8 (T5.AzF or BpF RS), 19 hours 37 oC, 25 hours 4 oC
PBS
BpF ind +
BpF ind -
AzF non
AzF ind +
AzF ind -
Sample
 
Table 15:  Fluorescence analysis of Genehog cells expressing pSR8.010 and pML123 plasmids 
containing BpF and AzF synthetase shown as non-induced (non), IPTG-induced (ind-) or IPTG 
and UAA induced (ind+).  Test suggests functional tRNA/RS pairs in Genehog strain as per 
increased fluorescence with ind+ > ind-. 
Initially, DC3000: pSR8.010: pSR8.044 (AzFRS) strains did not show significant 
fluorescence in cells or in supernatant fractions (Table 13).  In fact, cells induced with IPTG in 
presence of showed lower RFU/OD values than non-induced or IPTG-induced cultures.  It was 
considered that because p-azido-L-phenylalanine contains an azide bond able to undergo light-
induced reduction to p-amino-L-tyrosine, AzFRS could not to charge this degradation product to 
the cognate tRNA.  To confirm this possibility an additional growth test was performed with all 
flasks wrapped in aluminum foil for the duration of the experiment.  As expected, Table 16 shows 
transformed DC3000 cultures in presence of both IPTG and AzF produced nearly two-fold the 
fluorescence of IPTG-only or non-induced cultures.  Therefore, it is shown that the dual plasmid 
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system using the modified M. jannaschii Tyr-tRNA
CUA
 in concert with the corresponding AzF-
charging synthetase yields successful incorporation of p-azido-L-phenylalanine to give full-length 
fluorescing GFPuvN149-AzF.  There was no attempt at purifying GPFuvN149-AzF for 
visualization on SDS-PAGE or by Western blot detection from this final aluminum foil covering 
experiment.  Future studies with AzF should allow for foil or other light-blocking covering.   
Sample ODfluor RFU Dev. RFU/OD Reported Dev. 
Blank N/A 0.333333 9.626353 N/A 0.333 9.63 
Non 0.1 54.5 9.949874 545 545 9.95 
Ind-  0.1 64.5 14.59795 645 645 14.6 
Ind+ 0.1 125.2 17.25399 1252 1250 17.3 
 
Table 16:  Duplicate DC3000:pSR8.010:pSR8.044 cultures were foil-covered and grown for 42 
hours at 30
o
C before setting at 4
o
C for an additional 20 hours.  Cultures were diluted to OD600 0.1 
for fluorescence analysis of non-induced (non), IPTG-induced (ind-), and IPTG with AzF (ind+).   
 This thesis has shown that the unnatural amino acids, BpF and AzF (Figure 18), can be 
utilized in vivo by P. syringae DC3000 containing an exogenous tRNA/RS pair to suppress the 
TAG stop codon and produce full-length reporter proteins.  It was noted that the levels of 
fluorescence were not as high as expected in DC3000 and so the GFPuvN149TAG plasmid 
(pSR8.010) and the plasmid pair including the wild-type TyrRS  in E. coli NEB5α F’ cells was 
performed to attempt further characterizing of the this system’s effectiveness.  NEB5α F’ cells 
(New England Biolabs) contain suppressor tRNA, supE44, are able produce full length 
GFPuvN149TAG proteins with an installed glutamine (Singaravelan, 2010).  Although results 
showed expected increased fluorescence (Table 17, Table 18) they also confirmed that the system 
was producing lower fluorescence in all organisms.  It was decided to alter the promoter 
sequences for the tRNA
CUA 
in attempt to increase the productivity of this dual plasmid system. 
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Figure 18:  Crosslinking phenylalanine derivatives investigated in this study for incorporation 
into TAG stop codon sites by M. jannaschii Tyr-tRNA in presence of evolved cognate M. 
jannaschii TyrRS synthetase: AzF (left) or BpF (right).  
RFU Dev. OD600 RFU/OD Reported
2.778 6.671 N/A N/A N/A
12.000 5.585 0.10 120.000 120
23.556 10.277 0.10 235.556 240
NEB5α F' with pSR8.010 only (19 hours 37 oC, 25 hours 4 oC)
ind -
non
PBS
Sample
 
Table 17:  Fluorescence analysis of NEB5α F’ cells expressing pSR8.010.  Test shows 
functionality of GFPuv N149TAG under IPTG-induced (T5) promotion for fluorescence of ind- > 
non. 
RFU Dev. OD600 RFU/OD Reported
0.222 7.190 N/A N/A N/A
160.667 8.958 0.10 1606.667 1600
292.333 15.827 0.10 2923.333 29008+8 (Tyr) ind -
8+8 (Tyr) non
PBS
Sample
NEB5α F' :pSR8.010:pSR8.037 (19 hours 37 oC, 25 hours 4 oC)
 
Table 18:  Fluorescence analysis of NEB5α F’ cells expressing pSR8.010 and pSR8.037.  Test 
shows successful working of dual plasmid system that includes TyrRS WT (8+8 (Tyr)) as 
fluorescence for IPTG-induced (ind-) is greater than non-induced (non). 
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3.4 New Mj. Tyrosyl-tRNA Promoters:  lpp and proK 
 
Figure 19:  DNA gel for plated cells of pBBR-GFPuvN149 (v; top left) with either lpp cassette 
(+lpp; bottom) or proK cassette (+proK; top-right). 
A single trial time-point experiment was performed to test if there was increased 
transcription of Tyr-tRNA and therefore heightened fluorescence of full-length GFPuv N149BpF 
mutant protein.  Cell-based fluorescence results did not show that promoter, proK, gave any 
higher RFU for samples induced by IPTG and BpF.  After the first trial, no more studies into the 
proK promoter cassette were performed.  Initial results for the lpp promotion cassette showed 
promise and subsequent trials were performed to give varying results.  It was noted that when 
cells fluoresced greater for IPTG and UAA-induced samples these values seemed slightly higher 
than for the tRNA-met-3 promoter-based plasmids.  A higher amount of protein was therefore 
purified form 28 mL cultures to compare the tRNA-met-3 cassette and the lpp cassette.     
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RFU/OD Dev. Reported Dev. RFU/OD Dev. Reported Dev. RFU/OD Dev. Reported Dev.
-- -- -0.26 0.11 -- -- 0.00 0.11 -- -- 0.00 0.11
2218.889 -- 2220 -- 3826.667 -- 3830 -- 5585.556 -- 5590 --
1887.037 767.866 1890 768 3184.097 11.490 3180 11.5 2942.546 936.065 2940 936
2019.506 250.543 2020 251 3354.653 220.283 3350 220 5026.944 956.558 5030 957
3128.796 1026.156 3130 1030 4362.583 1264.071 4360 1260 3349.753 454.469 3350 455DC:lpp:BpF ind+
Blank
72 hrs 30 oC, 20 hrs 4 oC 96 hrs. 30 oC, 20 hrs. 4 oC 120 hrs. 30 oC, 20 hrs. 4 oC
Sample
DC WT
DC:lpp:BpF non
DC:lpp:BpF ind-
 
Table 19:  Average fluorescence of cells over 4 trials for DC3000:pSR8.052.1:pSR8.017 
(DC:lpp:BpF) against wild-type DC3000 (DC WT).  Cultures for transformed cells were either 
non-induced (non), IPTG-induced (ind-), or induced with IPTG and 1 mM BpF (ind+).  Although 
two samples showed increasing fluorescence in the order of ind+ > ind- > non, the other two 
cultures did not showed ind- > ind+. 
Based on the fluorescence results, combined with lack of detection by Western blot 
(Figure 27), it is noted that the lpp promoter cassette did not augment GFPuvN149 expression.  In 
fact, the only tRNA promoter system to give successful incorporation of BpF into GPFuvN149 is 
for the native P. syringae DC3000 as found in vector pSR8.010 (Figure 26, 27, 28). 
3.5.1 Investigating Secretion of Full-length GFPuv N149 Mutants in Liquid Culture 
During a replicate trial for DC3000:6.067 (Pyl-tRNA, GFPuv N149TAG), there appeared 
a greenish-glow in the liquid cultures after cell pellet collection, after a period of 120 hours.  This 
fluorescence suggested there was significant full-length GFPuv in the culture supernatant that 
could be seen by eyesight.  In presence of 365 nm light, even non-induced liquid sample featured 
a more intense green fluorescence.  Therefore, it was decided to test other strains with tRNA and 
GFPuv N149TAG only, as well as DC3000 wild-type and DC3000 expressing the GFPuv WT. 
Subsequent observance of GFPuv WT fluorescence in the culture supernatant lead to culture 
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other DC3000 strains to see if cell-pellet based fluorescence results could be supplemented by 
any full-length GFPuv N149 mutants lost to the culture broth. 
Attempts to normalize relative fluorescence of sample supernatants failed due to (a) 
inconsistent homogeneity of collected time-points which could not always be remedied by 
pipetting of solution, and (b) negative values of A280 (mg/mL) readings against KB-T as a blank 
for various time-points.  Eventually, as no samples except the GFPuv WT cultures provided His-
tagged proteins under Western blot detection, the inability to normalize liquid culture samples is 
not seen as a severe problem in this study. 
However, it was regarded that wild-type DC3000 secretes small molecules, especially 
siderophores such as pyoverdin (Jones, 2007), and other molecular bodies that possess 
fluorescence.  To account for this, liquid cultures of wild-type DC3000 samples at given time-
points were analyzed for fluorescence.  Finally, a series of analyses for KB-T broth with added 
tetracycline at 10 µg/mL acts as an additional corrective factor for the supernatant cultures with 
GFPuv (WT or N149TAG) and tRNA vector. 
To observe if full-length GFPuv N149 mutants were expressed and secreted into culture 
milieu, samples were analyzed over several days post-induction.  All time-points were taken from 
the same initial induced culture.  Fluorescent analysis featured multiple reads on same sample as 
load to two or three wells in microplate.  These triplicates were necessary as incident irradiation 
of GFPuv causes quenching and reduced fluorescence in second and later exposures. Culture 
supernatant samples were excited at 390 nm with emission detection at 510 nm as for cells. 
To detect any full-length GFPuv mutants in the liquid supernatant, cultures were induced 
and incubated from 48 to 120 hours.  Liquid culture supernatant fractions were analyzed by 
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fluorescence assay.  Tetracycline in KB-T was additionally analyzed during intermittent 
fluorescence reads to obtain average emission for antibiotic at 510 nm of 670. +/- 239 RFU; this 
value is not featured in correction unless otherwise noted. 
  Interestingly, there was a consistency for IPTG-only induced cultures showing higher 
supernatant fluorescence than IPTG with UAA fluorescence for strains, DC3000:pSR6.067 +/- 
PylRS (WT or Y348F) and DC3000:pSR8.010 +/- RS (TyrRS WT, BpFRS or AzFRS), as well as 
strains featuring alternative tRNA promoters, lpp and proK.  To further confirm no GFPuvN149 
mutants were being secreted into the liquid culture, Western blot detection against 6xHis antibody 
was performed and the resulting images are shown in Figures 21-25. 
3.5.2 Purification of GFPuv WT from DC3000 Supernatant 
GFPuv WT has been expressed in DC3000 and was secreted into the media.  GFPuv WT 
was purified from combined supernatant fractions (48, 72, 96-hours P.I.) and visualized on SDS-
PAGE gel (Figure 20).  Fractions featuring GFPuv WT were combined, concentrated, and later 
used as loading control for GFPuvN149 mutant analysis in transformed strains. 
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Figure 20:  SDS-PAGE results for GFPuv WT purification from DC3000 liquid media.  Protein 
began significant elution at 50 mM imidazole (W2-1) showing an expected 27.8 kD band, 
equivalent to full-length GFPuv-6xHis.  (Lanes annotated as left to right: 1, empty; 2, protein 
ladder; 3, 500 mM imidazole wash fraction; 4, 100 mM imidazole wash fraction; 5, 74 mM 
imidazole wash fraction; 6, 50 mM imidazole wash fraction part 2; 7, 50 mM imidazole wash 
fraction part 1; 8, 25 mM imidazole wash fraction part 2; 9, 25 mM imidazole wash fraction part 
1; 10, 3x flow-through (FT) fraction). 
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3.5.3 GFPuv WT Western Blot Analysis 
 
Figure 21:  Western blot membrane showing GFPuv products recognized by 6xHis antibody.  
Time-points are for hours post-induction in DC3000 culture expressing either GFPuv WT, GFPuv 
N149 TAG along with Mb. Pyl-tRNA (6.067), or none (WT).  GFPuv WT-6xHis is 27.8 kD in 
size and is the prominent band in the five right-hand lanes.  No His-tagged GFPuv N149 mutant 
was seen in combined wash fractions from 6.067.  (Lanes can be annotated as left to right: 1, 
pre-stained protein ladder; 2, 6.067 concentrated purification fraction 3 and 4; 3, 6.067 
concentrated purification fraction 50 mM imidazole; 4, pre-stained protein ladder; 5, DC3000 
WT 120-hour culture supernatant; 6, combined 120-hour DC3000:GFPuv WT supernatant; 7, 
DC3000:GFPuv WT 96-hour IPTG-induced supernatant; 8, DC3000:GFPuv WT 96-hour non-
induced supernatant; 9, DC3000:GFPuv WT 72-hour IPTG-induced supernatant; 8, 
DC3000:GFPuv WT 72-hour non-induced supernatant). 
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3.6.1 Western Blot for 6.067 
As supplement to previous fluorescence studies, Figure 21, lanes 2 and 3, shows 
concentrated fractions of purified supernatants from DC3000:6.067 96-hour induced and 
incubated cultures did not reveal 6xHis-tagged protein.   
3.6.2 Medium-scale (25 mL) DC3000:6.067 Purification  
It was plausible that a higher cell density of DC3000:pSR6.067 IPTG-induced culture 
could produce a significant amount of full-length GFPuvN149 mutants.  Purification and 
concentration of 25 mL supernatant for 96-hour incubated IPTG-induced DC3000:6.067 was 
performed and examined by Western blot.  However, there was no detected full-length GFPuv 
N149 mutant, suggesting that the original liquid culture fluorescence observation was not 
GFPuvN149 dependent.     
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Figure 22:  Western blot for detecting full-length GFPuv mutant in DC3000:6.067 purification 
fractions alongside GFPuv WT loading control (27.8 kD). Lane order, left to right:  1, pre-
stained marker; 2, DC3000:pSR6.067 25 mL ind- purification fraction; 3, DC3000:pSR6.067 
non-induced fraction; 4, GFPuv WT control. 
 There was no further investigation into the fluorescence of the DC3000:pSR6.067 strain 
and it was therefore assumed that the intensity of green tint to the liquid cultures that had inspired 
this supernatant-based inquiry was due solely to small molecules produced by DC3000 in the KB-
T broth.  It was still necessary to examine others cultures for GFPuvN149 in culture supernatant. 
3.7 Western Blot for 96-hour Culture Liquids Media 
Because it was seen that wild-type GFPuv was produced in cells and even secreted in 
high amounts into the liquid media, it was considered that any full-length GFPuv N149-UAA 
could also have been secreted into the milieu and therefore the cell-based fluorescence screening 
would not accurately represent the level of mutant GFPuv expression.   It was necessary to grow 
DC3000 strains as induced +/- unnatural amino acids over the same time-course for the wild-type 
GFPuv-expressing strain.  All cultures were prepared as above and grown for 5 days, as 
mentioned above.  Liquid media samples at 96- and 120-hour time-points were analyzed by 
Western blot.  However, there was no indication that any samples besides the DC3000:GFPuv 
WT expression strain secreted any full-length GFPuv N149 mutants.  It should be noted that the 
AzFRS transformants (pSR8.010:pSR8.044) were not wrapped in foil for this experiment.  
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Figure 23:  Western blot for nitrocellulose membrane showing select 96-hour post-induction 
samples from DC3000 strains.  Only the pre-stained protein ladder and the GFPuv WT load 
control (27.8 kD) feature apparent bands, suggesting there was no full-length GFPuv N149 
mutants being secreted into the culture.  Loading pattern (left to right):  1, DC3000 WT (DC WT) 
96-hour culture broth; 2, DC3000:pBBR1MCS3-GFPuv N149TAG non-induced; 3, 
DC3000:pBBR1MCS3-GFPuv N149TAG ind- (IPTG induced); 4, DC3000:pSR8.010 non-
induced; 5, DC3000:pSR8.010 ind- (IPTG induced ); 6, DC3000:pSR8.052.2 non-induced; 7, 
DC3000:pSR8.052.2 ind- (IPTG induced); 8, DC3000:pSR8.010:pSR8.044 non-induced; 9, ind- 
(IPTG only); 10, ind+ (IPTG + 1 mM AzF); 11, pre-stained protein ladder; 12, GFPuv WT 
control; 13, empty.  
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3.8 Western Blot for DC3000:pSR8.010: pSR8.017 and DC3000:pSR8.052.1: pSR8.017 
Fluorescence assays routinely showed expected results of increased fluorescence with 
unnatural amino acid addition of p-benzoyl-L-phenylalanine (BpF).  It was therefore necessary to 
ensure that no full-length GFPuv N149BpF mutants were being secreted into the liquid culture.  
Western blot detection of 96- and 120- hour cultures did not show any 6xHis-tagged proteins in 
those fractions, as compared with the loading control, GFPuv WT-6xHis which was purified 
directly from DC3000:GFPuv WT supernatant fractions.  This confirms that is no full-length 
GFPuv N149BpF mutant being secreted.  It is possible that there is either (a) truncated GFPuv 
N149TAG polypeptides being secreted, or (b) full-length GFPuv N149 mutants with a cleaved 
6xHis-tag, but these are both unlikely as (a) truncated GFPuv would have to be formed in very 
high amounts before being secreted and (b) the probability of selective removal of the C-terminal 
His-tag would still suggest that supernatant fluorescence values would still be very high even if 
protein could not be detected by Western blot. 
 
Figure 24:  Western blot nitrocellulose membrane showing results from 
DC3000:pSR8.010:pSR8.017 non-induced (n), IPTG-induced (-) and IPTG-induced with 1 mM 
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BpF (+) in 96 and 120-hour culture supernatants.  Only the GFPuv WT load marker (27.8 kD) 
and the pre-stained protein ladder feature any band appearance, suggesting there was no full-
length GFPuv N149 mutants being secreted into the culture.  (Lane order, left to right:  1, 96 hrs. 
non-induced; 2, 96 hrs. IPTG-induced; 3, 96 hrs. IPTG and BpF induced; 4, 120 hrs. non-
induced; 5, 120 hrs. IPTG-induced; 6, 120 hrs. IPTG and BpF induced; 7, pre-stained ladder; 8, 
GFPuv WT control; 9, empty lane; 10, empty lane.   
 
Figure 25:  Western blot nitrocellulose membrane showing results from 
DC3000:pSR8.052.1:pSR8.017 non-induced (non), IPTG-induced (ind -) and IPTG-induced with 
1 mM BpF (ind +) in 96 and 120-hour culture supernatants.  Only the GFPuv WT load marker 
(27.8 kD) and the pre-stained protein ladder feature any band appearance, suggesting there was 
no full-length GFPuv N149 mutants being secreted into the culture.  Lane order, left to right:  1, 
96 hrs. non-induced; 2, 96 hrs. IPTG-induced; 3, 96 hrs. IPTG and BpF induced; 4, 120 hrs. 
non-induced; 5, 120 hrs. IPTG-induced; 6, 120 hrs. IPTG and BpF induced; 7, pre-stained 
ladder; 8, GFPuv WT control; 9, empty lane; 10, empty lane.  Position of lanes shown on 
membrane are approximate for samples without apparent bands. 
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3.9 Mid-scale Culture for DC:pSR8.010:BpFRS, DC:8.052.1: BpFRS 
Purification of GFPuv N149BpF protein from 50-hour incubated induced DC3000 cultures 
featuring the evolved BpFRS and the corresponding M. jannaschii Tyr-tRNA with either the 
tRNA-met-3 or the lpp promotor cassette was performed. 
 
Figure 26:  15% SDS-PAGE gel showing purification fractions of GFPuv N149BpF from 
DC3000:pSR8.010:pSR8.017 featuring tRNA-met-3 promoter.  Full-length GFPuv N149 mutant 
is shown in lanes for W2-1, W2-2, W3-1, and W3-2.  Lane order, left to right:  1, 3x flow-
through; 2, W1-1 (25 mM imidazole); 3, W2-1 (50 mM imidazole); 4, W2-2; 5, W3-1 (75 mM 
imidazole); 6, W3-2; 7, W4-1 (100 mM imidazole); 8, W5 (500 mM imidazole); 9, GFPuv WT 
control; 10, unstained protein ladder. 
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Figure 27:  Western blot nitrocellulose membrane showing purification fractions of GFPuv 
N149BpF from DC3000:pSR8.010:pSR8.017 (010+BpF) and DC3000:pSR8.052.1:pSR8.017 
(lpp+BpF).  Full-length GFPuv (WT or N149BpF) features 6xHis-tag and is appears for GFPuv 
WT control (27.8 kD) and 010+BpF wash fractions 2, 3, and 4.  Lane order, left to right:  1, pre-
stained ladder; 2, lpp+BpF W4-1; 3, lpp+BpF W3-1; 4, lpp+BpF W2-1; 5, lpp+BpF W1-1; 6, 
GFPuv WT control; 7, 010+BpF W4-1; 8,  010+BpF W3-1; 9,  010+BpF W2-1; 10, 010+BpF 
W1-1.   
 Expression of GPFuvN149BpF from P. syringae DC3000 has been shown in both 
fluorescence studies and protein purification (Table 11, Figure 27).  In addition, fluorescence data 
from Table 16 shows that GFPuvN149AzF full-length protein can be expressed in DC3000.  
Therefore, it is reasonable to suspect other unnatural amino acids – recognized by other evolved 
M. jannaschii tyrosyl-synthetase – could be incorporated in P. syringae DC3000 using this 
system.  These results are proof of the success of the present invention for incorporation of 
unnatural amino acids in the plant pathogen 
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3.10 Further Increasing the Efficiency of Working Parts 
It should be possible to increase expression of the synthetase in plasmid pML123 by 
substituting for the T5 promoter and terminator regions with the neomycin promoter and 
terminator sequences to flank the synthetase insert.  It was shown by Labes, et al. in 1990 that the 
neomycin promoting cassette yields very high protein expression for β-galactose in soil bacteria 
and lower expression levels in E. coli (Table 20).  This could be suitable for studies involving 
molecular probes, although effector studies may require weaker promotion. 
Plasmid 
(promoter) 
E. coli R. meliloti R. leguminosarum P. putida 
  
βGal Nm βGal Nm βGal Nm βGal Nm 
pML122lac (pNM) 1400 R 21800 R 13900 R 16300 R 
pML130lac (plac) 2000 R 9050 R 6250 R 9800 R 
pML132lac (tac) 11300 R 2850 R 1150 R 2950 R 
pML140lac (pS1) 40 S 3300 R 1200 R 3350 R 
without plasmids 16 S 110 S 130 S 150 S 
            
Table 20:  βGal activities and NmR gene expression of vectors carrying the lacZ and NmR genes in 
Gram- hosts.  Literature reference featured neomycin (Nm) at 100 μg/mL working concentration; 
βGal units are as Miller units.  (R, resistant; S, susceptible; adapted from Labes, 1990; Table II). 
Another promoter to considerably enhance the expression of biomolecules (reporter, 
synthetase, and even effector proteins) for this UAA incorporation system is the Amaranthus 
hybridus chloroplast promoter, PpsbA, as found in plasmid pDSK-GFPuv (Wang, 2007).  This 
plasmid was designed for mobility and attachment assays of phytopathogens in planta, especially 
for the use of mutated GFPuv proteins as biological probes in plant pathogens and their hosts.  
Indeed, pathogen-expressed probe/effector fused to a Type III secretion signal would be greatly 
benefitted by use of such a strong promoter.  As PpsbA is constitutive, in planta studies of 
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infection may have to be optimized against for severe overexpression of particularly active 
effector proteins – a dead specimen is not as good for study as one surviving. 
 
Figure 28:  Plasmid map of pDSK-GFPuv featuring GFPuv under promotion of psbA chloroplast 
promoter (PpsbA) and T7 gene10 ribosome binding site (RBS). {Retrieved from Wang, 2007} 
3.11 Secretion of GFPuv WT from DC3000, Revisited 
One unexpected result of this study shows that overexpression of the wild-type GFPuv 
protein in DC3000 produces a GFPuv-dependent fluorescent supernatant that emits differently 
than any siderophore-based fluorescence produced by the strain.  This process appeared even 
within 48 hours of GFPuv expression in the bacteria, suggesting the GFPuv was likely due to 
protein secreted from live bacteria, whether than being the residual molecular species from 
culture-contained burst cells.    As the live bacteria pellets also showed fluorescence, it is likely 
there is a maximal expression amount that can exist within the organism before subsequent 
secretion of full-length protein into the culture broth.  It is also reasonable to suspect the GFPuv 
content of the liquid, just as in the cells, was not as aggregation and was fully-folded, as non-
folded and aggregated forms of GFP (and most likely GFPuv) do not fluoresce (Heim, 1994; 
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Tanudji, 2002).  This secretion event was likely to keep the intracellular compartments from 
bursting under increasing cellular stress at longer time-points.  Incidentally, it was also observed 
(data not shown) that liquid culture supernatants for DC3000:GFPuv WT showed increased 
fluorescence over DC3000 wild-type in LB media – a richer nutrient broth that would therefore 
negate any mineral deficiencies for the bacterial strain and thereby making repressing the usual 
secretion of metal-chelating siderophores.  This occurred even after 1.5 hours post-induction 
(data not shown), and further supports the possibility that GFPuv was not being released by dead 
bacterial cells.  It has not been determined by what method these GFPuv WT proteins were being 
secreted, although it can be assumed the process does not involve virulence-based Type III 
secretion system (T3SS) as the GFPuv WT protein did not feature a T3SS signal motif, nor did 
the GFPuv WT contain any other secretion-related peptide signals.  Further insight into this 
process would require very strong expression of the GFPuv N149-BpF mutant, with which one 
could instigate UV-induced crosslinking of the mutant protein to covalently attach to its exporting 
protein partner(s).  Additionally, if a high concentration of expressed proteins, such as antibiotic 
resistance proteins not needed for environmental survival, were to be present at high levels in the 
supernatant, then there may be further interest in using P. syringae DC3000 as a lower 
temperature organism for production of biomolecules for research or educational resources.  An 
example experiment would include transformation of DC3000 cells with a plasmid containing 
both kanamycin and gentamycin acetyltransferase, but for the transformants to be grown only in 
gentamycin liquid stock.  Presumably, protein electrophoresis or more sensitive blotting 
techniques (e.g. for kanamycin fused to a 6xHis-tag and induced by IPTG) would quantify any 
supernatant-localized secreted proteins. 
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3.12 Possible Role of P. syringae pv. tomato DC3000 as Resource for Primary, Junior, and 
Secondary Education 
Given the easy acquisition of GFPuv from the culture media, it is also likely that other 
proteins over expressed in DC3000 may be secreted into the liquid media, thus allowing a nearly 
continuous supply of expressed protein in the supernatant that could be purified by various 
methods.  This supernatant-extraction process could be considered especially useful in 
laboratories lacking sufficient lysis methods – including primary, middle, and secondary school 
science labs.  Indeed, this would also allow for such small laboratories experiments to have no 
need of toxic chemicals such as phenol and chloroform, caustic or heavy denaturing agents, or 
sonication or pressurized-lysis instruments.  It has not been observed that strains of E. coli K-12 
cells expressing GFPuv will secrete this full-length protein into their liquid culture a without 
specialized secretion signals (Mergulhao, 2005) or selective permeation (Penna, 2002).  DC3000, 
therefore, can be considered a less time-involved species for producing some biological products.   
 Consequently, because P. syringae pv. tomato DC3000 is not a human pathogen and is 
not suited for epiphytic survival, and because the species can grow at a range of temperatures, 
from 4 
o
C to 30 
o
C, room temperature cultures can be incubated on older model shakers and even 
on sterilized bench, allowing financially-burdened or frugal laboratories to study microbiological 
techniques with little need of expensive incubation chambers.  Protein purification would be 
facile for younger students as this particular strain expressed a GFPuv WT with a terminal 6xHis-
tag.  After collecting supernatant samples, students could gain practice of purifying proteins and 
build an understanding of useful analytical techniques.  For GFPuv, specifically, subsequent 
study of the fluorescence due to proper protein folding at differing pH levels, temperatures or in 
differing chaotropic agents, such as urea or other amines will help the students understand how 
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protein activity (analogizing enzymes to fluorescent proteins) is dependent upon specific 
environmental factors.  Finally, should one possess strains that can produce inexpensive mutant 
GFPuv biological probes, this would allow students to use such tools to understand more of the 
complex chemistry occurring in biological systems.  Regardless, these characteristics – for wild-
type GFPuv or mutants – also enable students to study the bacteria and the plant host (e.g. S. 
lycopersicum or A. thaliana) interactions, for both the tomato plant and the Arabidopsis can be 
easily grown in a make-shift, moderately sterilized laboratory area.     
3.13 Expanding the Usefulness of the Present Invention 
Although the direct feature of this plasmid system relates to using the benzophenone and 
azido derivatives of phenylalanine, other unnatural amino acids can be incorporated given the 
properly-evolved synthetase.  In literature to date, there have been a large number of UAAs 
constructed, any of which could ideally be featured in formed mutated proteins – proteins that 
could not only capture host cell targets or partners within the bacteria itself (e.g. transcription 
factors or scaffold and transporter proteins), but also for study of cellular dynamics, such as free-
flow of molecular species in situ or redox-related changes using a reporter protein capable of 
losing fluorescence, quantitatively, in presence of hydrogen peroxide,  hydrogen sulfide, ionic 
mineral concentrations (Fang, 2012; Niu, 2013), nitric oxide, or other signaling molecules.  In 
addition, in situ studies are not limited to using a specialized form of the GFPuv protein as a 
biological probe.  This current study was developed with the intent of incorporation crosslinking 
amino acids, notable BpF and AzF, into secreted effector proteins and capturing their host targets 
during the natural infection process of the P. syringae pv. tomato DC3000 phytopathogen and A. 
thaliana or S. lycopersicum.  However, this thesis work can be extended to other organisms. 
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There are over 50 pathovars of P. syringae, alone (Xin, 2013), and it is expected that the 
present dual plasmid system is applicable direct study of these pathovars with their individual 
hosts.  This would be especially beneficial for species such as bean pathovar, P. syringae pv. 
syringae B728a, which is a model pathogen for study of epiphytes’ sensing of the extra-host 
environment (UV, wind, temperature).  With an alteration of either the tRNA or the synthetase 
species, this UAA-incorporation system can be used for study in other plant pathogenic bacteria.  
The two parent plasmids used in this system are characteristically broad-host range bacterial 
expression plasmids.  Notable prokaryotes for study include Erwinia spp., Xanthomonas spp., 
Rhizobium spp. (Hueck, 1998), or agriculturally-beneficial bacteria, such as Lysobacter 
enzymogenes (Wang, 2013), and even Agrobacterium tumefaciens – peaking interest in both 
pathogen-based and plant transformation studies.  UAA-based modifications of L. enzymogenes 
proteins should be easily accomplished by substituting the tRNA vector, pBBR1MCS3 (Tet
R
) 
with its chloramphenicol resistance marker counterpart, pBBR1MCS (Kovak, 1995), as this 
bacteria is resistant to common antibiotics, excepting gentamycin and chloramphenicol (Wang, 
2013).  And certainly, successful use A. tumefaciens to transform plant species with UAA-
incorporating machinery would open a large field of biotechnological study. 
Incorporation of UAAs into any of the above bacteria, for example, requires  (a) no 
significant TAG stop codon suppression tRNA native to the system -- although concerns on this 
point are minimal (Povolotskaya, 2012), (b) that there is no suppression of other stop codons if 
they are used less frequently than TAG, (c) a suitable pair of exogenous tRNA/RS, for example, 
M. barkeri, or M. jannaschii, or other biological species (Chatterjee, 2012), orthogonal to the host 
organism’s native translation machinery, (d) a species for study that is capable utilize the selected 
unnatural amino acid, and (e) promoting cassette(s) optimal for yielding satisfactory expression 
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of all exogenous molecules without causing unnecessary toxicity to the bacterium or, if 
applicable, the later infected host.  For most requirements the methods will be similar to what has 
been described herein.  This thesis can therefore be a starting guide to produce a set of optimized 
working components for the incorporation of unnatural amino acids for study of intracellular and 
extracellular environmental events such as bacterial-host molecular interactions and this basis of 
disease. 
This thesis presents the methods and resulting success for incorporation unnatural amino 
acids into the model plant pathogen, Pseudomonas syringae pv tomato DC3000 – a task that had 
not yet been performed – and thus produces a new tool for researchers to study the molecular 
mechanisms involved in bacterial pathogen-host interactions.
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Chapter 4.  Materials and Methods 
4.1 Common Instruments and Hardware 
Nanowater was provided from Barnstead Nanopure (Thermo Scientific); Isotemp 2320 water 
bath, Nanodrop 2000, Precision incubation chambers, and MaxQ 8000 incubation shakers 
(Thermo Fisher); digital analytical balances (Mettler Toledo); Manual single-channel pipettes 
(Rainin; Mettler Toledo); pipet tips, polystyrene plates, analog vortex mixer, Digital Heat Block 
(250 V), and hot plate/stirrer, 50 mL conical tubes, and electroporation cuvettes were purchased 
from VWR; culture tubes, PCR tubes (0.25 mL), laboratory glassware, and additional 50 mL 
conical tubes from Fisherbrand; Mastercycler thermocycler, Mini Spin Plus centrifuge, 
Centrifuge 5424, and Electroporator 2510 (Eppendorf); Allegra X6-R bench-top model 
(Beckman-Coulter); Axygen 0.6 mL and 1.5 mL centrifuge tubes (Corning); sonication of cells 
performed with Model 120 Sonic Dismembrator (Fisher Scientific); and all images for DNA gels, 
SDS-PAGE gels, agar plates, and Western blot colorimetric development of membranes were 
obtained by GelDoc XR+ imaging system with ImageLab software (BioRad). 
4.2 Bacterial Cell Preparations 
4.2.1 Preparation of Liquid and Solid Culture Media: LB and KB-T 
E. coli cells required use of lysogeny broth (LB) as prepared with LB broth media 
(Teknova).  LB/agar plates were prepared with additional of 15.0 g/L agar (Criterion by Hardy) 
and, following autoclave sterilization of LB/agar mixture, appropriate working concentration of 
antibiotics. 
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P. syringae pv. tomato DC3000 cells required use of modified King’s B medium with 
tryptone substituted for peptone.  The modified medium contains 9 mM K2HPO4, 1.6 mM 
MgSO4*7H2O, 1% v/v glycerol, pH 7.0, with added 2% w/w tryptone (Bacto; BD).  KB-T agar 
plates were prepared with additional of 18.0 g/L agar and, after autoclave sterilization, 
appropriate working concentration of antibiotics. 
It can be noted that P. syringae pv. tomato DC3000 is naturally resistant to both rifampin 
(as per the genotype) and also chloramphenicol, presumably at concentrations less than 17 
µg/mL.  However, growth of wild-type strain was done without addition of any antibiotics. 
All culture media reagents were purchased from Sigma-Aldrich unless otherwise stated.  
MgSO4*7H2O was purchased from EMD Millipore.  All nanowater was autoclaved before use. 
4.2.2 Preparation of Chemical Competent Cells 
 Chemical competent cells were prepared in CCMB media and store at -80 
o
C until use.  
CCMB media components: {CaCl2*2H2O (80 mM), MnCl2*4H2O (20 mM), MgCl2*6H2O (10 
mM), potassium acetate (10 mM), glycerol (10% v/v), pH 6.4}; media was sterilized through 0.2 
um filter (VWR) and stored at 4 
o
C. Reagents were purchased from Sigma Aldrich (CaCl2*2H2O, 
MnCl2*4H2O, glycerol) and Fisher (MgCl2*6H2O and potassium acetate). 
 Chemical competent cells were prepared as follows:  overnight inoculants were grown at 
37 
o
C, 250 rpm before subculture into 100 mL LB.  Subcultures were incubated to OD600 0.4 to 
0.6, then cells were collected over two rounds of centrifugation {5000 x g, 10 min}.  Broth was 
decanted and cells were suspended in 1 mL CCMB media, collected as above, and recovered in 4 
mL CCMB.  Aliquots were prepared for storage in 1.5 mL or 0.6 mL tubes.  In some 
experiments, liquid ratios were fixed but volume was reduced. 
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4.2.3 Transformation of Cells 
All transformations for E. coli strains, Genehog, NEB5α (New England Biolabs), or 
NEB5α F’ (Wei Niu, University of Nebraska-Lincoln), were performed via heat shock method for 
chemical-competent cells stored at -80 
o
C.  Plasmid DNA was added at 10%, or less, cell volumes 
and set on ice for 10 minutes before incubated at 37 
o
C for 30 seconds, with return to ice for 1-2 
minutes.  Heat shocked cells were recovered with either 500 µL lysogeny broth for Genehog and 
NEB5α transformations featuring Pyl-tRNA/RS system, or 10x initial cell volume of LB (for 
Genehog  cells featuring Mj. plasmids).  Recovered cells were incubated at 37 
o
C, 250 rpm for 
40-60 minutes in MaxQ 8000 shaker and then plated to pre-warmed (37 
o
C) LB/agar plates with 
appropriate antibiotics and plated cells incubated in 37 
o
C for 1 or 2 days in incubation chambers 
to obtain medium-sized colonies suitable for inoculation. 
All P. syringae pv. tomato DC3000 transformations were performed via electroporation 
using Electroporator 2510.  Previous to electroporation, cells were swabbed from 30 
o
C-warmed 
plates (1-60 days old) and suspended in 1 mL of cold (4 
o
C) 1 M HEPES, 10% glycerol (pH 6.8) 
by vortexing on high and centrifugation at 4 
o
C, 16 200 x g, 1 minute.  Cells were washed an 
additional two times in cold 1 mL HEPES/glycerol buffer, each, and final pellets were suspended 
by pipette in 60 µL on ice.  Plasmid DNA was added at 4 µL for 60 µL washed cells and this 
suspension was transferred to pre-chilled electroporation cuvette and kept on ice for 2 minutes 
before 2500 V pulsing to obtain time constant values between 1.4 and 5.4, depending on cell 
density in 60 µL suspension.  Immediately after pulse, 400 µL of cold KB-T broth was added to 
cuvette to recover cells, after which the volume was transferred to original 1.5 mL tube and set 
into 30 
o
C, 250 rpm for one hour of incubation in MaxQ 8000 shaker.  Incubated cells were plated 
to pre-warmed (30 
o
C) KB-T/agar plates at 150 µL cells per plate and set for 1-3 days in 30 
o
C 
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Precision chamber.  It can be noted that for any time constant in the range given, plated cells 
would generally grow well over an average 2-day period and plates featuring P. syringae DC3000 
transformants will continue to grow in 4 
o
C refrigerator up to 6-months if there is ample solid 
agar media for growth; colonies on these plates, however, will be yellowish-green in color, thick 
in biofilm, and sticky.   
Working concentrations of antibiotics included ampicillin (100 μg/mL), chloramphenicol 
(34 μg/mL), kanamycin (50 μg/mL), tetracycline (10 μg/mL), and gentamycin (10 μg/mL).  All 
antibiotic solutions (as mg/mL) were stored at -20 
o
C until needed and returned to freezer after 
use.  Ampicillin, chloramphenicol, and tetracycline were supplied by Calbiochem; kanamycin 
sulfate purchased from IBI Scientific; gentamycin was purchased from Teknova. 
4.3 Recombinant DNA Methods 
4.3.1 Plasmid DNA Miniprep 
All plasmid DNA was purified from overnight cell cultures following manufacturer’s 
protocol.  Three different miniprep kits were used in house during the duration of this project.  
For M. barkeri-related plasmids, PureYield Plasmid Miniprep Kit (Promega) was used, while for 
M. jannaschii-related plasmids, Zyppy Plasmid Miniprep Kit (Zymo Research), excluding vector 
pSR8.017, which was purified using GeneJET Plasmid Miniprep Kit (Thermo Scientific).  All 
plasmids were eluted in nanowater and DNA concentration tested at 260 nm with Nanodrop 
2000. 
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4.3.2 PCR Methods 
All polymerase chain reaction (PCR) procedures utilized autoclaved nanowater (ddH2O), KOD 
Hot Start Polymerase (KOD; EMD Millipore) and featured 30 cycle programs for denaturing, 
annealing, and extension stages of reaction.  Tables for reaction setup are shown in Appendix I. 
4.4 Preparation of Unnatural Amino Acid Reagent 
Amino acids used in this study included p-benzoyl-L-phenylalanine, p-azido-L-
phenylalanine, and boc-lysine (Bachem).  The amino acids, p-benzoyl-L-phenylalanine (BpF) and 
boc-lysine were stored at room temperature, while p-azido-L-phenylalanine (AzF) was stored at -
20 
o
C. 
Amino acid solutions were prepared in 0.6 mL, or 1.5 mL at a concentration of 14-60 
mM in 30% 1 M NaOH in nanowater {e.g. 2 mg BpF, 150 µL 1 M NaOH, 350 µL nanowater for 
a small scale culture of 1-5 mL}.  
4.5 Preparation of Cultures – Growth and Lysis 
4.5.1 Culture Growth 
Inoculants were prepared from plated cells at 30 
o
C or 4 
o
C, or from glycerol stocks (6 µL 
from -80 
o
C storage) into KB-T broth with appropriate working concentration of antibiotics (e.g. 
3 mL KB-T broth, 3 µL Gen
10
 stock, 2.6 µL Tet
12.5
 stock) and grown at 30 
o
C, 250 rpm for 16-48 
hours, until saturation (OD600 > 1.2).  Subcultures were then prepared in KB-T broth with 
antibiotics as OD600 of 0.4 and grown at 30 
o
C, 250 rpm to final OD 0.7-1.0.  These mid-log OD 
(optical density) cultures were charged with working concentrations of 0.5 mM IPTG (Fisher 
Scientific). 
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Where applicable, induction also required 1 mM BpF or AzF solution or 5 mM Boc-
lysine solution, followed by addition of 1 M HCl at 1:1 molar volume with NaOH in amino acid 
solution (e.g. for 150 µL NaOH in 500 uL total amino acid solution, addition of total volume to 
culture requires follow-up with 150 µL 1 M HCl.  Cultures were incubated until time-point 
collection and set into 4 
o
C refrigerator overnight for 16-20 hours before pelleting cells.  Wild-
type DC3000 was grown from 4 
o
C plates in KB-T with no antibiotics, followed by subculture to 
OD600 0.4 at the same time as transformed strains, and incubated for equal durations, including 4 
o
C overnight refrigeration and further sample preparation.   
4.5.2 Cell Lysis Methods 
Lysis of cells for protein analysis required re-suspension of collected cell pellets (4 
o
C, 
5000 x g, 10 min; Allegra X6-R) into 2 mL lysis buffer per 50 mL cell culture to allow for 
sonication of cells.  Sonication lysis buffer contained 20 mM Tris-HCl (Trizma; Sigma Aldrich), 
0.5 M NaCl, 10% glycerol and 10 mM imidazole, pH 8.0, unless otherwise noted.  Sonication 
was effected and total protein content was checked at 280 nm with Nanodrop 2000 to note protein 
concentration after complete bursting of cells. 
4.6 Purification of Proteins Featuring C-terminal His-tag 
All GFPuv-6xHis-tagged proteins expressed as full-length molecular species were 
purified using GE Ni
2+
-Sepharose resin (GE Healthcare) housed in Econo-Pac Chromatography 
Columns (BioRad).  Purification buffers were as for lysis buffer (3.5.2) except with wash #1 -5 
containing 25 mM, 50 mM, 75 mM, 100 mM, and 500 mM imidazole, resp.  Each washing step 
involved five column volumes of washing buffer, as per manufacturer’s protocol. Protein content 
in purification wash fractions was tested by Nanodrop 2000 with respective washing buffers (or 
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lysis buffer for total protein, soluble protein, and flow-through) as blank for mg/mL 
determination.  Where applicable, fractions containing protein of interest were combined and 
concentrated using either Amicon Ultra-4 Centrifugal Filter Unit or Amicon Ultra 0.5 mL 
Centrifugal Filter, each with 3000 kilodalton (kD) molecular weight cut-off.  All Amicon filters 
were used according to manufacturer’s protocol and centrifugations were performed at 4 oC in 
Sorvall Legend Micro 21R refrigerated microcentrifuge, for 0.5 mL Filter units, or using Allegra 
X6-R bench-top centrifuge.  For GFPuv proteins purified from DC3000 cultures, no storage 
buffer was prepared or used, as protein samples were not needed further for activity assays.   
4.7 DNA and Protein Analysis (SDS-PAGE) Methods: 
4.7.1 Preparation of DNA Electrophoresis Gels 
All DNA electrophoresis gels were made in house as 0.8-1.2% agarose (LE, analytical 
grade; Promega) in TAE buffer {200 mM Tris, 100 mM acetic acid, 5 mM EDTA, in nanowater} 
featuring ethidium bromide (Promega) as nuclei acid stain at 0.006-0.008% v/v.  DNA gels were 
solidified on Mini-Gel Caster and DNA gels were run in Mini Sub-Cell GT Cell or Wide Mini-
Sub Cell GT Cell powered by PowerPac Basic Power Supply (BioRad). 
4.7.2 Preparation of SDS-PAGE Gels 
Denaturing sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed using Mini-PROTEAN Tetra Cell electrophoresis chamber and a PowerPac Basic 
Power Supply (BioRad).  SDS-PAGE gels were made in house as 15% polyacrylamide resolving 
gel {25% nanowater, 25% Tris, pH 8.8} with a 10% polyacrylamide stacking gel {55% 
nanowater, 25% Tris, pH 6.8}.  Electrophoresis was performed in presence of Tris/glycine/SDS 
buffer {124 mM Tris, 960 mM glycine, 17 mM SDS, in nanowater}.  All SDS-PAGE protein 
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samples were loaded to prepared gels after mixing with 1:1 volume with 2x Laemli Buffer 
(BioRad) featuring 5% 2-mercaptoethanol (Sigma Aldrich) and boiled for 15 minutes at 91-98 
o
C.  
Unstained and pre-stained protein marker ladders (BioRad) were used and SDS-PAGE gels were 
typically run at either a constant 35 mA or constant 200 volts at room temperature.  After running 
SDS-PAGE gels were removed from cassette and rinsed in warmed water on rocker to remove 
protein sample dye, followed either by staining with Coomassie blue stain {70 mg Brilliant Blue 
G-250 (MW 854.02; Fisher Scientific) into 1.0 L nanowater with 3 mL conc. HCl; stir at room 
temperature for 4-6 hours} or directly used for Western blot. 
4.8 Western Blot Protein Detection 
SDS-PAGE gels rinsed in warmed water were soaked in cold (4 
o
C) Western blot transfer 
buffer {25 mM Tris, 192 mM glycine, 20% v/v methanol, pH 8.3-8.5} and set into transfer 
cassette against nitrocellulose membrane (BioRad).  Membrane transfer was performed at 
constant 100 volts for 1 hour in BioRad Mini Trans-Blot Cell transfer chamber at room 
temperature (RT) in cold transfer buffer.  Transferred membrane were cut for sizing with ethanol-
rinsed razor and rinsed twice in 10-15 mL PBS (BioRad; 0.5-1.0 NaCl, 0.1-0.25% sodium 
dihydrogen phosphate) with added 0.1% Tween-20 buffer (Sigma Aldrich) with rocking for five 
minutes at RT.  Membrane was then blocked overnight for 16-20 hours at 4 
o
C, with rocking, in 
3% blocking solution (BioRad) and then rinsed twice for 5 minutes in 10 mL PBST buffer.  
Primary antibody, 2 µL mouse αHis-tag  (Pierce prod #MA1-21315; Thermo Scientific) was 
added to PBS + 1% BSA (OmniPure, Calbiochem) for 1:3000 working dilution and membrane 
was incubated with rocking for 1-2 hours at RT, followed by five separate washes in 10 mL 
PBST for five minutes, each.  Secondary antibody, GαM-HRP (BioRad), was diluted to 1:3000 in 
PBS + 1% BSA {2 µL into 6 mL solvent} to the membrane and incubated for 1-1.5 hours on 
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room temperature rocker.  Membrane was then again rinsed five times for five minutes in 10 mL 
PBST, each.  Colorimetric detection of 6xHis-tagged protein samples on membrane was 
performed using Opti-4CN detection (BioRad) according to manufacturer’s protocol, which 
involved rocking at RT, covered from light, for 28-30 minutes.  All developed membranes were 
then rinsed twice for 5-10 minutes in nanowater before imaging on GelDoc XR+.   
4.9 Vector Construction and Plasmid-related Culture Preparations 
Initial GFPuv (WT and N149TAG), GFPuv/Pyl-tRNA and PylRS vector design was developed 
by Wei Niu (University of Nebraska-Lincoln).  Plasmids were constructed by the author of this 
work.  Setup and program methods for all PCR reactions are provided in Appendix I.  All 
restriction enzymes were purchased from New England Biolabs, unless otherwise noted.  All 
plasmid maps were designed by the author with SnapGene software {http://www.snapgene.com}, 
excluding those from cited reference. 
4.9.1 pBBR1MCS3-GPFuv N149TAG and pBBR1MCS3-GFPuv WT 
Vector pBBR1MCS3 was used for construction of pBBRMCS3-GPFuv N149TAG and 
pBBRMCS3-GFPuv WT.  Parent vector, pBBR1MCS3, was cut with XbaI and dephosphorylated 
for 1 hour with Antarctic Phosphatase (New England Biolabs) at 37 
o
C, followed by heat 
inactivation of enzyme for 5 minutes at 80 
o
C.  Both GFPuv N149TAG and GFPuv WT (wild-
type) were cut from their respective pLei-GFPuv vector (group lab stocks) using NheI and XbaI 
to feature a 1.1 kb band, and digestions were followed by 1-hour dephosphorylation as for parent 
vector.  All plasmid digestions were performed at 37 
o
C for 3 hours and restricted plasmids were 
purified via gel electrophoresis with recovery via ZymoClean Gel DNA Recover Kit (Zymo 
Research), or directly (pBBR1MCS3) by same Zymo Research column purification kit.  Ligation 
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of restricted vector and insert was performed at room temperature for 1 hour with T4 Hot Start 
ligase (Thermo Scientific) and samples were then set on ice prior to transformation of E. coli 
chemical competent cell via heat shock method, or transformation of DC3000 via electroporation.  
All pBBR1MCS3 constructs evoke tetracycline resistance to viable transformants. 
 
Figure 29:  Plasmid map for pBBR1MCS3-GFPuv (WT or N149TAG) 
 4.9.2 pBBR1MCS3-GFPuv N149TAG-Mb. Pyl-tRNA (pSR6.067) 
Design of vector containing the exogenous tRNA utilized a constitutive promoter based 
on the native TRNA-met-3 promoter region in DC3000.  The upstream region was amplified via 
polymerase chain reaction (PCR) from chromosomal DNA using Pure-link Genomic DNA Kit 
(Invitrogen) with primers, tRNA-pBBR-F1-KpnI (5’-GTG GTA CCG ACC TGA TGG GAT TTT 
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GCA ATC AAT G-3’ ) and tRNA-pBBR-R1 (5’-TCT GTG TGT CGG CAT TCT ACA GAG-3’), 
resulting in a 253 bp product which was used after purification (Zymo Research) for overlapping 
PCR with the M. barkeri pyrrolysyl-tRNA sequence (150 bp) amplified from plasmid, pLei-PylT 
(group stock).  The Pyl-tRNA primers were, tRNA-pBBR-F2 (5’-GAA TGC CGA CAC ACA GAG 
GAA ACC TGA TCA TGT AGA TC-3’)  and, New-tRNA-pBBR-R2 (5’-GAG ACT GCA GCC TTT 
TTT GAT GTT TGG CGG AAA CCC CGG GAA TCT A-3’).  The underlined regions in primers, 
tRNA-pBBR-F1-KpnI and New-tRNA-pBBR-R2, show the enzyme cutting sites, KpnI and PstI, 
respectively.  Initial overlapping PCR design featured the terminator region of TRNA-met-3, 
rather than a generic poly-A tail, but failure in the annealing stage inspired use of fewer primers 
pairs.  All PCR reaction involved KOD Polymerase (EMD Millipore).  Overlapping PCR was 
performed with 15 ng/uL DNA templates and primers, tRNA-pBBR-F1-KpnI and New-tRNA-
pBBR-R2 at 69.5 
o
C annealing temperature to yield product which was digested with KpnI and 
PstI and purified by DNA gel electrophoresis and column purified. 
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Figure 30:  Illustration of overlapping PCR showing regions (R1 and F2) overlapped and primers 
(F1 and R2) used during final PCR program.  Restriction sites, KpnI and PstI are shown in 
original fragments and final combined PCR product. 
 Next, vector pBBR1MCS3:GFPuv N149TAG (KpnI, PstI) was ligated with prepared Pyl-
tRNA fragment (KpnI, PstI) to obtain purified plasmid with proper insert.  This new construct, 
pSR6.067, contains the GFPuv N149TAG mutant reporter protein, as well as the exogenous Pyl-
tRNA flanked by the native DC3000 tRNA-met-3 promoter (upstream) and a general terminator 
region.  This construct ensures recognition of the exogenous Pyl-tRNA by the DC3000 
transcription machinery and promotion of the reporter protein under T5-based IPTG induction.     
 To test for successful ligation, three colonies were picked for separate inoculations of LB 
broth with added tetracycline, grown 19 hours at 37 
o
C, 250 rpm, and after cell collection and 
miniprep, plasmids were digested with HindIII for 1 hour at 37 
o
C before analysis on 1.0% DNA 
agarose gel. 
 Plasmid pSR6.067 was transformed into wild-type DC3000 and plated cells were used to 
inoculate KB-T (Tet
10
) media and grown at 30 
o
C, 250 rpm before subculture and growth to mid-
log OD600.  Induced cultures (IPTG) were examined for cell-based fluorescence.   
A repeat trial of DC3000:pSR6.067 fluorescence in cells was performed for a 5-day 
period to ensure no Pyl-tRNA interaction with DC3000 translation machinery.  For this 
experiment, glycerol stock was used to inoculate KB-T broth with added tetracycline and samples 
were shaken at 30 
o
C to saturation, and a 4 mL subculture prepared at OD600 0.4, and induced at 
mid-log OD600.  Time-points of 48, 72, 96, and 120-hours post-induction were collected as per 
2.9.11 and analyzed as described. 
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Figure 31:  Plasmid map for pSR6.067 (M. barkeri Pyl-tRNA; KpnI, PstI; GFPuv N149TAG). 
4.9.3 pML123-tac.PylRS WT 
The M. mazei pyrrolysine synthetase (PylRS) was PCR amplified using primers, 5’GAG 
AAT TCA TGG ATA AAA AAC CAT TAG ATG-3’ and 5’- GCT CTA GAG CGA AGC GGA 
ATT AA TTC GCG AAG-3’, featuring EcoRI and XbaI cutting sites (underlined), respectively, 
from vector pBK-PylRS (Hao, 2011) and purified (Zymo Research) before digestion by EcoRI 
and XbaI.  Similarly, modified vector pJF118EH-mod1 (Furste, 1986; modification by Wei Niu, 
University of Nebraska-Lincoln) was digested with EcoRI and XbaI purified by DNA gel 
electrophoresis and column purification with ZymoClean Gel DNA Recover Kit (Zymo 
Research).  Ligation of restricted vector and PylRS insert was performed for 2 hours at room 
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temperature with Hot Start T4 Ligase and ligation product transformed into strain, NEB5α, 
followed by plating to LB/ampicillin agar plate.   
Plasmid, pJF118EH-PylRS, contains a promoter cassette featuring tac.RBS.PylRS which 
was amplified using primers, PylRS118toML-B (5’-GAG GAT CCT TAT CCG GTG CAC CAA 
TG-3’) and PylRS118toML-H (5’-CGT TCT GAT TTA ACT GTA TCA GGC TG-3’), and PCR 
product (1.797 kb) was purified and digested with restriction enzymes, BamHI and HindIII, 
isolated by DNA gel electrophoresis and purified by column purification.  In addition, plasmid 
pML123 was digested with BamHI and HindIII and isolated via DNA gel electrophoresis and 
column purification.  Cut vector, pML123, and the PylRS insert were ligated for 4 hours at room 
temperature, followed by transformation into NEB5α and plating to LB/gentamycin agar plate. 
 
Figure 32:  Plasmid map for pML123.tac.PylRS (WT, Y348F, PylRS
NAA
) into BamHI, HindIII. 
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4.9.4 pML123-tac.PylRS Y348F 
As for the tac-PylRS (2.9.3), the synthetase cassette was PCR amplified from pBK vector 
using primers, 5’GAG AAT TCA TGG ATA AAA AAC CAT TAG ATG-3’ and 5’- GCT CTA 
GAG CGA AGC GGA ATT AA TTC GCG AAG-3’, featuring EcoRI and XbaI cutting sites 
(underlined), respectively, from vector pBK-PylRS Y348F (group stock) and digested with EcoRI 
and XbaI for ligation into vector pJF118EH-mod1.  Subsequent steps for inserting tac.PylRS 
Y348F cassette into pML123 (BamHI/HindIII) were also as for wild-type PylRS (3.9.3). 
This plasmid featuring the mutated PylRS was co-transformed into Genehog and DC3000 
cells along with vector, pSR6.067, for fluorescence analysis of cells induced with IPTG only (ind 
-) or IPTG and 5 mM boc-lysine (ind +) and grown overnight at resp. incubation temperatures, 
following overnight incubation without shaking at 4 oC. 
For a 48-hour study DC3000 cells containing plasmid pSR6.067 alone, or with 
pML123.tac.PylRS (WT or 368F) were cultured and induced (where applicable) with IPTG and 
boc-lysine.  1 mL samples were pulled from 30 
o
C incubated cultures, stored overnight (12 hours) 
at 4 
o
C, and then centrifuged {10 min, 16 000 x g, 4 
o
C} and stored at -80 
o
C until time of 
fluorescence reading.  Reconstituted cells were washed three times in PBS buffer and examined 
for RFU, then OD600 values were read and RFU/OD calculated for comparison.    
4.9.5 pML123-tac.PylRS-NAA Mutant 
From a PylRS Y348F synthetase library stock in our group labeled, BL-5, cells at 10
7
 and 
10
5
 dilutions were plated on LB/Tet
12.5
/Kan
50
/Cm
100
 agar plates and mid-sized colonies were used 
to inoculate liquid LB media with appropriate antibiotic concentrations.  Plasmids were purified 
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and transformed into E. coli “pREP-PylT” cells for positive selection by plating on 
LB/Tet
25
/Kan
50
/Cm
50 
plates.   
From the BL-5 library plating, 2 colonies were selected from 10
7 
dilution plating, used to 
inoculate liquid and streaked to produce 100s of CFU and two were picked for inoculation and 
plasmid purification.  The PylRS Y348F fragment was successfully amplified with PCR primers 
used for PylRS WT (4.9.3), the PCR product was digested, and ligated into pJF118EH-mod1 to 
produce pJF-PylRS Y348F.  From this pJF-PylRS Y348F, the tac.RBS.PylRS Y348F cassette 
was amplified as before (4.9.3), restricted (BamHI/HindIII) and inserted into prepared pML123 
(BamHI/HindIII).  Six colonies of transformants featuring pML123-PylRS Y348F were analyzed 
and vector pSR7.040.6 was obtained.  This vector, containing evolved PylRS Y348F to recognize 
natural amino acid (NAA) was transformed into DC3000:pSR6.067 or co-transformed with 
pSR6.067 into Genehog.  Inoculations were prepared as before and induced at mid-log OD600 
with 0.3 mM IPTG and grown at respective temperatures before overnight incubation at 4 
o
C and 
cell-based fluorescence analysis. 
4.9.6 pBBR1MCS3.T5-PylRS WT, pML123.T5-PylRS WT, and pML123.T5-PylRS Y348F 
According to Figure 32, shown below, PCR amplification of PylRS (WT or Y368F) from 
resp. pBK-PylRS initial PCR amplified products of PylRS or PylRS Y348F were digested with 
EcoRI and XbaI as before (4.9.3) and inserted into pET28a (Invitrogen) within EcoRI and XbaI 
sites to produce pET28a-PylRS WT and pET28a-PylRS Y348F.  Plasmids were purified by 
miniprep and digested by NdeI and SacI for ligation into the pLei-GFPuvN149TAG vector (NdeI, 
SacI), which had been digested to remove the GFPuv protein, but kept the T5.RBS cassette and 
the 6xHis tag.  Ligation was successful and transformation into Genehog c.c. cells allowed for 
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miniprep and subsequent digestion with NheI and XbaI.  Vectors pBBR1MCS3 and pML123 
were both digested with XbaI and dephosphorylated with Antarctic phosphatase.  Ligation of the 
T5.RBS.PylRS (WT or Y348F) cassette into both vectors was performed for 4 hours at room 
temperature. 
The new synthetase plasmids, pML123.T5.PylRS (WT or Y348F) were transformed into 
DC3000 and Genehog cells for cell-based fluorescence readings.  A series of experiments were 
then conducted to test incorporation in cultures induced with IPTG and boc-lysine at (a) 20- and 
42-hours post-induction, (b) 12-hour time-point collection (12-48 hours total), and cultures 
induced with IPTG and boc-lysine (ind +) or as IPTG-only (ind -). 
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Figure 33: Construction scheme for pBBR1MCS3.T5.PylRS (WT and Y348F) (shown) and 
pML123.T5.PylRS (WT and Y348F) (not shown); both feature the same final digestion (XbaI). 
4.9.7 Introduction of the M. jannaschii Tyrosyl-tRNA and RS System 
The following details the development of a system for incorporation of unnatural amino 
acids into the model plant pathogen, P. syringae pv. tomato DC3000.   
4.9.7.1 Construction of pBBR-GFPuv N149TAG-M. jannaschii Tyrosyl-tRNA (pSR8.010) 
To construct vector pSR8.010, containing the M. jannaschii Tyrosyl-tRNA, it was 
required to implement overlapping PCR methods similar to the Pyl-tRNA vector (pSR6.067) 
construction shown in 3.9.2.  Primers used for amplifying the Tyr-tRNA from its pLei vector 
were: MjtRNA-pBBR-F2 (5’-GAA TGC CGA CAC ACA GAC CGG CGG TAG TTC AGC AGG-
3’) and MjtRNA-pBBR-R2 (5’-GAG ACT GCA GCC TTT TTT GAT GTT TGG TCC GGC GGG 
CCG GAT TTG A-3’).  Subsequent overlapping with TRNA-met-3 promoter region required 15 
ng/uL DNA templates and primers, tRNA-pBBR-F1-KpnI and MjtRNA-pBBR-R2 at 69.5 
o
C 
annealing temperature.  The overlapping PCR product was digested with KpnI and PstI, isolated 
by DNA gel electrophoresis and column purified before ligation in KpnI, PstI-digested pSR6.067.  
The final construct, pSR8.010 features the Tyr-tRNA
CUA 
from M. jannaschii (Mj.) as well as the 
GFPuv N149TAG reporter protein. 
DC3000 wild-type cells were transformed with pSR8.010 for inoculation in KB-T culture 
and incubation with or without addition of 0.5 mM IPTG for cell-based fluorescence test in 
comparison to DC:6.067 induction with or without addition of 0.5 mM IPTG. 
80 
 
 
In addition, a single fluorescence test of 120-hour P.I.  DC3000 cultures expressing 
pSR8.010 was performed.  Mid-log cultures were induced with 0.5 mM IPTG (ind-), and incubate 
at 30 
o
C, 250 rpm for 120 hours, followed by 18 hours at 4 
o
C.  1 mL of collected cells were 
washed 3x in PBS (500 µL) before analysis.  OD600 values were obtained at 10x dilution of 
culture sample and back-calculated for RFU/OD results. 
 
Figure 34:  Plasmid map for pSR8.010 (M. jannaschii Tyr-tRNA,KpnI, PstI; GFPuv N149TAG) 
4.9.7.2 pML123.T5-BpFRS (pSR8.017) 
Mj. Tyr RS evolved to specifically recognize the unnatural amino acid, p-benzoyl-L-
phenylalanine (BpF) was amplified out of plasmid pBK-BpFRS using PCR primers, R1-YRS-
pML123-T5 and TyRS-lib1-F1-NdeI (Nanxi Wang, University of Nebraska-Lincoln).  The 
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sequence for primer, R1-YRS-pML123-T5 (5’-TAT TGA GCT CCT GCA GTT ATA ATC TCT 
TTC-3’), features a SacI cutting site (underlined), while primer, TyRS-lib1-F1-NdeI (5’-TTG 
AGG AAT CCC ATA TGG ACG A-3’) contains an NdeI cutting site (underlined).  Afterward, 
the PCR product was digested with NdeI, SacI, and ligated for 3.75 hours into the intermediate 
pLei-GFPuv N149TAG-Mj. Tyr-tRNA
CUA
 , which had been previously digested (NdeI, SacI) to 
remove the GFPuv protein for constructing the T5.RBS. Mj. Tyr-tRNA
CUA 
cassette.  This cassette 
was removed from vector (XbaI, NheI) and inserted into pML123 (XbaI) to produce pSR8.017.  
Plasmid pSR8.017 was used to transform DC3000 cells to yield strains DC3000:pSR8.017 and 
DC3000:pSR8.010:pSR8.017. 
An initial fluorescence test was performed for cells featuring pSR8.010 and pSR8.017.  
Plated cells were used to inoculated KB-T broth with gentamycin and tetracycline and grown 
overnight to saturation.  Subcultures were prepared and induced at mid-log OD600, induced, and 
were incubated for 36 hours at 30 
o
C, 250 rpm, then set for 24 hours at 4 
o
C before collecting 1 
mL of each culture {4 
o
C, 16 000 x g, 8 min} and storage at -80 
o
C until fluorescence assay 
preparation.  Thawed cultures were resuspended in equal volume of PBS and OD600 values were 
taken at 10x dilution and then back-calculated for RFU/OD values after.   
In addition, replicates were performed to average of fluorescence data for three trials for 
DC3000:pSR8.010:pSR8.017.  All cells were prepared as before and incubated post-induction for 
44-48 hours followed by 20 hours at 4 
o
C without shaking.  Cell pellets were prepared as 
described for fluorescence analysis with examined samples either normalized to OD600 0.1 or 
directly at OD600 0.8 to 1.2. 
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Figure 35:  Plasmid map for pSR8.017 (pML123.T5.BpFRS; XbaI); pSR8.044 is similar. 
4.9.8 pML123.T5-TyrRS WT (pSR8.037) 
To help understand reasons for apparent low incorporation of BpF into GFPuv N149TAG 
present in DC3000, the wild-type tyrosyl-tRNA synthetase (TyrRS WT, or TyrRS) was inserted 
into the pML123 synthetase vector under promotion of T5 with the corresponding RBS found in 
previous T5 cassettes from pLei vectors:  From vector pBK-MjTyrRS (Chin, 2002), the TyrRS 
was PCR amplified using the same primers as for the BpFRS from its corresponding pBK vector, 
followed by digestion with NdeI and SacI.  Digested TyrRS fragment was inserted into pLei 
vector to replace GFPuv protein DNA sequence (NdeI, SacI) and vector pLei-TyrRS WT was 
then restricted by BamHI and XhoI to produce insert fragment for ligation into pML123 (BamHI, 
XhoI).  It was necessary to use lab-produced strain, Genehog F`, featuring an F` fertility plasmid 
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with gentamycin resistance.  Therefore, plasmid miniprep required inoculation into LB media 
with kanamycin instead of gentamycin – possible because pML123 contains both gentamycin and 
kanamycin resistance markers.  The final product, vector pSR8.037 featured the wild-type TyrRS 
that is counterpart to the M. jannaschii Tyr-tRNA present in vector pSR8.010. 
Cultures were inoculated, grown to saturation OD600, and sub-cultured for induction with 
and without IPTG (0.5 mM working concentration) for growth at 30 
o
C, 250 rpm.  Cultures for 
fluorescence assays were collected at determined time-points and stored overnight at 4 
o
C before 
fluorescence analysis of cell pellets or liquid culture suspensions.  An initial 36-hour trial was 
performed, followed by a series of 44-48 hours induction experiments. 
 
Figure 36:  Plasmid map for pSR8.037 (pML123.T5.TyrRS WT; BamHI, XhoI) 
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4.9.9 pML123.T5-AzFRS (pSR8.044) 
Synthetase vector, pSR8.044, was constructed as follows:  AzFRS sequence was PCR 
amplified from pBK-AzFRS using the same primers used for BpFRS and TyrRS (4.9.7, 4.9.8).  
As before, PCR product was digested with NdeI and SacI.  Digested AzFRS fragment was 
inserted into pLei vector to replace GFPuv protein DNA sequence (NdeI, SacI) and vector pLei-
AzF was then restricted with NheI and XbaI and ligated into pML123 (XbaI).  The final construct, 
pSR8.044 is able to selectively recognize p-azido-L-phenylalanine for charging onto the cognate 
tyrosyl-tRNA
CUA
 found in pSR8.010. 
DC3000 transformants harboring plasmids pSR8.010 and pSR8.044 were prepared and 
tested for fluorescence of cells after 36 hours of incubation in presence on IPTG with and without 
addition of 1 mM AzF and with or without covering culture flasks in aluminum foil. 
To compliment studies in DC3000, pSR8.010 and corresponding synthetase vectors were 
transformed into Genehog (BpFRS, AzFRS) or NEB5α F’ competent cells (TyrRS WT).  Single 
colonies were used to inoculate LB broth with appropriate antibiotics and after subculture of 
saturated inoculants, strains in liquid media were induced with 0.5 mM IPTG working 
concentration and, where applicable, 1 mM BpF or AzF.  No added tyrosine was given to NEB5α 
F’:pSR8.010:pSR8.037 (TyrRS) cells.  Cultures were grown overnight at 37 oC, 250 rpm, then set 
at 4 
o
C or 16-20 hours before pelleting, washing in PBS, and fluorescence analysis after dilution 
to OD 0.1.   
4.9.10 New Mj. Tyrosyl-tRNA Promoters:  lpp and proK 
To attempt an increase in the Tyr-tRNA transcription, two additional promoters were 
substituted in place of the original tRNA-met-3 sequence from DC3000.   
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From vector pLei-GFPuv N149TAG-Mj Tyr-tRNA the lpp.MjtRNA.terminator cassette 
featuring the lpp promoter and terminator regions flanking the Tyr-tRNA was amplified by PCR 
using primers, lpp-tRNA-F-KpnI (5’-GAG AGA GGG TAC CCG GGA TGT GCT GCA AGG CGA 
TTA AG-3’) and lpp-tRNA-R-XmaI (5’-ATA TAT CCC GGG CCC TGG CGC CGC TTC TTT 
GAG-3’) which contain KpnI and XmaI restriction sites, resp.  Digestion of fragment at noted 
cutting sites allowed for ligation into pBBR1MCS3-GFPuv N149TAG (KpnI, XmaI) to produce 
pSR8.052.1.  This plasmid was transformed into DC3000 WT and DC:pSR8.017 (pML123-
BpFRS) and this strain was further analyzed for cell-based and culture supernatant fluorescence. 
Vector pSR8.052.2, implementing the proK promoter and terminator (term.) regions, was 
prepared similarly as for the lpp promoting cassette.  proK.MjtRNA.term was PCR amplified 
from pEvol vector (Young, 2010) using primers, proK-tRNA-F-KpnI (5’-GAG AGA GGG TAC 
CGA GCA CCG GTT TAT TGA CTA CC-3’) and proK-tRNA-R-XmaI (5’-ATA TAT CCC GGG 
TTT TTT AAG GCA GTT ATT GGT-3’) which feature restriction sites for KpnI and XmaI, 
respectively.  PCR product was digested with restriction enzymes for the noted cutting sites, 
isolated by DNA gel electrophoresis and column purification, and ligated into plasmid 
pBBR1MCS3-GFPuv N149TAG (KpnI, XmaI) to produce pSR8.052.1.  This plasmid was 
transformed into DC3000 WT and DC:pSR8.017 (pML123-BpFRS) and this strain was further 
analyzed for cell-based and culture supernatant fluorescence. 
 DC3000 cells featuring pSR8.017 (BpFRS) were transformed with tRNA plasmids 
featuring either the lpp, or proK promoters and plated cells were used for inoculation of KB-T 
broth with added antibiotics.  Cells were grown alongside DC3000:pSR8.010:pSR8.017 for one 
or two days to saturation, subculture was prepared and then induced at mid-log OD.  Induced 
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cultures were grown for several days with time-points collected at 48, 72 hours.  Cell pellets and 
liquid culture supernatant were analyzed for fluorescence. 
 Three additional series of DC3000 cultures harboring pSR8.052.1 (lpp) and pSR8.017 
plasmids were prepared as above and examined for fluorescence of cell pellets over several days.   
 
Figure 37:  Plasmid map for pSR8.052.1 (lpp promoter/Mj. Tyr-tRNA; KpnI, XmaI) 
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Figure 38:  Plasmid map for pSR8.052.2 (proK promoter/Mj. Tyr-tRNA; KpnI, XmaI) 
4.10 GFPuv Purification from DC3000 Liquid Broth 
Inoculants were prepared from plated cells at 30 
o
C or 4 
o
C, or from glycerol stocks (6 µL 
from -80 
o
C storage) into KB-T broth with appropriate working concentration of antibiotics (e.g. 
3 mL KB-T broth, 3 µL Gen
10
 stock, 2.6 µL Tet
12.5
 stock) and grown at 30 
o
C, 250 rpm for 16-48 
hours, until saturation (OD600 > 1.2).  Subcultures were then prepared in KB-T broth with 
antibiotics as OD600 of 0.4 and grown at 30 
o
C, 250 rpm to final OD 0.7-1.0.  Induction of mid-log 
OD cultures featured working concentrations of 0.5 mM IPTG and 1 mM BpF or AzF solution or 
5 mM Boc-lysine solution.  Cultures were incubated until time-points of 48, 72, 96, and 120-
hours post-induction (P.I.) from which 250-300 µL volumes were taken from incubated culture 
stock and set into 4 
o
C refrigerator overnight (16-20 hours).  Wild-type DC3000 was grown from 
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4 
o
C plates in KB-T with no antibiotics, followed by subculture to OD600 0.4 at the same time as 
transformed strains and incubated for equal durations, including 4 
o
C overnight refrigeration and 
further sample preparation. 
Cell pellets for all time-points were collected from liquid cultures at 4 
o
C, 21 100 x g, 15 
minutes and supernatants were transferred to 0.6 mL tubes for storage on ice.  Pellets were 
washed in equal volume of PBS solution {10 mM Na2HPO4, 140 mM NaCl, pH 7.0} with 
vortexing, followed by centrifugation at 4 
o
C, 14 000 x g, 10 minutes for a total of three washes.   
All collected cell pellets or liquid media for each time-point was stored at -80 
o
C or 4 
o
C, 
respectively, to allow for multiple sample fluorescence analysis on the same day.  Liquid media 
for time-points was kept at -20 
o
C or -80 
o
C after fluorescence analysis for later use in Western 
blot detection. 
Samples were loaded to 15% prepared SDS-PAGE gel after boiling at 94 
o
C for 15.5 
minutes in presence of equal volume 2x Laemli buffer.  Loaded samples were run in Tris/Glycine 
buffer at either constant current of 35 mA to 38 mA or constant voltage of 200 V.  After 
electrophoresis, gel was washed in warmed nanowater at room temperature until blue dye on gel 
had dissipated and then either stained in Coomassie blue staining solution or used directly for 
Western blot transfer. 
4.11 GFPuv WT Western Blot 
Liquid media samples from DC3000 expressing GFPuv WT at 72, 96, and 120 hours 
post-induction (P.I.) were measured for protein concentration (mg/mL) at 280 nm with Nanodrop 
2000.  Higher concentrated samples were normalized to 25 µg for loading to 15% SDS-PAGE gel 
and further His-tag detection using Western blot colorimetric method.  These time-points were 
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loaded alongside normalized sample of DC3000 WT secretion (liquid media) at 120 hours P.I.  
Additionally, 20 µL volumes of concentrated fraction from DC3000 featuring M. barkeri Pyl-
tRNA and GFPuv N149TAG mutant (pSR6.067 non-induced and IPTG induced) were loaded to 
SDS-PAGE gel for comparison under Western blot detection 
4.12 Western Blot for 6.067 
To determine if DC3000:pSR6.067 cultures contained secreted GFPuvN149-XX, 
combined purification fractions at wash #2 (50 mM imidazole) and wash #3, 4 (75 mM, 100 mM 
imidazole) were analyzed against DC3000:GFPuv WT supernatants (4.9.12) and DC WT 120-
hours supernatant samples.  280 nm absorbance readings of these fractions did not show 
appreciable protein concentration, so 20 µL of each was mixed with equal volume of Laemli 
loading buffer for sample preparation and loading to SDS-PAGE gel. 
4.13 Purification of GFPuv N149-BpF from Medium-scale Culture for DC:6.067  
To ensure there is no GFPuv N149TAG-XX mutant being expressed and secreted to the 
culture supernatant, a 25 mL scale culture was prepared and purification of possible full-length 
GFPuv N149-XX mutant was attempted. 
A 2.5 mL volume of KB-T broth was inoculated with plated cells and grown to saturation 
in presence of tetracycline and gentamycin.  A 1.0 mL portion of the inoculant was added to 25 
mL KB-T (with 25 µL Gen
10
 stock, 20 µL Tet
12.5
 stock) and grown at 30 
o
C, 250 rpm to OD600 of 
0.8.  Culture was then separated as 2 mL for non-induced and 24 mL for induction with IPTG at 
0.5 mM working concentration.  Cultures were grown at 30 
o
C, 250 rpm for 96 hours before 
setting overnight (20 hours) at 4 
o
C.  250 µL of each raw suspension was then prepared for 
supernatant and cell-based fluorescence analysis, while the remaining portions were centrifuged 
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for supernatant extraction, and supernatants were frozen at -20 
o
C until purification.  For original 
250 µL aliquots, 30 mg of each induced and non-induced were lyzed in Tris/glycerol lysis buffer 
(pH 8.0) and protein concentration detection with Nanodrop 2000 at 280 nm.  50 µg each total 
protein portion was then prepared for SDS-PAGE and western blot analysis alongside GFPuv WT 
supernatant samples from DC3000 (4.9.12). 
The supernatant fraction (~ 24 mL) of the induced DC3000:pSR6.067 culture was thawed 
overnight at 4 
o
C and loaded to column with 1 mL Ni
2+
-Sepharose resin.  Flow-through (FT) was 
reloaded twice before washing with 25 mM imidazole in wash #1, followed by wash buffer series 
#2-5 (50-500 mM imidazole).  Washes #2-5 were combined and concentrated by Amicon Ultra-4 
Centrifuge Device to 300 µL prior to storage at 4 
o
C.   
4.14 Western Blot for 96-hour Culture Liquids Media 
96-hour culture supernatants were analyzed by Western blot protocol to determine if any 
full-length GFPuv N149 mutant was had been secreted by DC3000.  Supernatant samples were 
examined for protein concentration (mg/mL) with Nanodrop 2000 and normalized to 25 µg total 
protein before SDS-PAGE sample preparations (Laemli dye, boiling) and loading to gel alongside 
GFPuv WT loading control.  Electrophoresis gel was then transferred to nitrocellulose membrane 
and membrane was incubated and developed as previously described, but featuring 1.5 hours 
incubation for both primary and secondary antibodies.  Membrane was developed and image was 
captured.   
The 96-hour samples analyzed during this trial included DC3000 WT 96-hrs, GFPuv 
N149TAG only (non, induced IPTG), pSR8.010 only (non, induced IPTG), pSR8.052.2 (proK) 
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only (non, induced IPTG), pSR8.010:pSR8.037 (non, induced IPTG), and pSR8.010:pSR8.044 
(AzFRS; non, induced IPTG, induced IPTG with 1 mM AzF). 
4.15 Western Blot for DC:pSR8.010: pSR8.017 (BpF) and DC:pSR8.052.1 (lpp): pSR8.017 
To ensure no full-length GFPuv-N149BpF mutants were being secreted into the liquid 
media, 96-hour and 120-hour supernatant samples were prepared for SDS-PAGE and Western 
blot detection with 6x-His antibody.  Nanodrop 2000 was used to obtain protein concentrations 
(mg/mL) at 280 nm and samples for loading were prepared at 25 µg total protein based on those 
280 nm readings.  Samples were loaded to 15% SDS-PAGE gel and later transferred to 
nitrocellulose membrane.  Overnight blocking in 3% blocking buffer was performed at 4 
o
C, with 
rocking, and subsequent incubation of the membrane at RT in presence of primary (1.5 hours) 
and secondary (1.5 hours) antibodies, with a final colorimetric development were all performed.  
Membrane blot was imaged. 
4.16 Purification of GFPuv N149-BpF from Medium-scale Culture for 
DC:pSR8.010:pSR8.017 and DC:pSR8.052.1 (lpp):pSR8.017 
Medium-scale (28 mL) cultures of DC3000 featuring either pSR8.010 + pSR8.017 
(BpFRS) or pSR8.052.1 (lpp) + pSR8.017 were prepared as follows:  2.5 mL KB-T was 
inoculated from glycerol stock (pSR8.010 + pSR8.017) or agar plate stored at 4 
o
C for 2 months 
(pSR8.052.1 + pSR8.017) and incubated with antibiotics at 30 
o
C, 250 rpm overnight.  Cultures 
were then directly added to 25 mL KB-T in 125 mL Erlenmeyer flask with added antibiotics and 
grown to OD600 of 1.0.  At this time, 2 mL of each was transferred to culture tube to serve as 
possible non-induced control, while the remaining fractions were induced with 500 µL of 55.7 
mM BpF solution {15 mg BpF, 300 µL 1 M NaOH, 700 µL ddH2O}, 150 µL 1 M HCl (to 
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neutralize NaOH}, and 140 µL 100 mM IPTG (0.5 mM working concentration).  All cultures 
were then incubated for 50 hours at 30 
o
C, 250 rpm.  500 uL of initial induced suspensions were 
transferred to 1.5 mL centrifuge tubes for supernatant and cell pellet fluorescence analysis.  The 
remaining cultures were collected {4 
o
C, 5000 x g, 50 minutes} and stored at -80 
o
C until lysis 
and purification.  Lysis was performed in 3 mL (pSR8.010 + BpFRS) or 6 mL (pSR8.052.1 + 
BpFRS) of lysis buffer {50 mM Tris, 100 mM NaCl, 1 mM EDTA, pH 8.0} with sonication on 
ice until lysate samples were clear {5 minute rounds on ice as: 10 sec. pulse, 30 sec. pause, 60-
65% power; 5 rounds (pSR8.010 + BpFRS) or 7 rounds (pSR8.052.1 + BpFRS) total} and lysates 
were frozen immediately at -80 
o
C until centrifugation and lysis supernatant collection {4 
o
C, 21 
100 x g, 30 min}.  Select purification fractions of DC:pSR8.010:pSR8.017 were analyzed by 
SDS-PAGE, while fractions (Wash #1-1, 2-1, 3-1, 4-1) for both induced strains were analyzed by 
Western blot.  Relevant purification fractions from both were analyzed for protein concentration 
at 280 nm with Nanodrop 2000 with appropriate lysis and wash buffers as blanks.  Where 
applicable, protein samples were normalized to 25 µg for gel loading. 
4.17 Fluorescence Assays 
All fluorescence assays were performed using the SynergyH1 microplate reader (BioTek) 
with Costar 96-well black flat-bottom fluorescence plates (#3915; Corning).  All readings were 
performed at 19-25 
o
C ambient temperature with 100x gain, 7.0 mm read height, and excitation at 
390 nm with emission at 510 nm.  Sample buffer included blanking in phosphate-buffered saline 
solution (PBS) {10 mM Na2HPO4, 140 mM NaCl, pH 7.0}.   
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4.17.1 Cell Pellets 
Pellets of cells were washed three times in equal volume of PBS buffer {4
o
C, 14 000 x g, 
10 minutes each} as preparation for analysis.  Cell pellet suspensions were homogenized as best 
able and liquid-only portions were assayed.  Fluorescence readings were performed on cell pellets 
after testing optical density at 600 nm (OD or OD600) at 10x dilution {i.e. 100 µL per 900 µL 
nanowater} or 20x dilution {i.e. 50 µL sample per 950 µL nanowater}, depending on the turbidity 
of the culture.  Unless otherwise noted, samples were normalized to OD = 0.05 or OD 0.1 before 
loading to black flat-bottom microplate at volumes of 125 µL sample per well.   
Blanking of analyzed samples was performed with PBS only for cell pellets, unless 
otherwise noted. 
4.17.2 Cell Culture Liquid Supernatant 
Supernatants for cultures were analyzed as 5 µL liquid media in 120 µL PBS buffer.  An 
additional reading was performed for a solution of either KB-T in PBS or KB-T/Tet
10
 in PBS.  
Over the series of sample readings, values for KB-T/Tet
10
 (5 µL solution into 120 µL PBS) were 
averaged for correction against fluorescence caused by tetracycline in the culture broth. 
Blanking of analyzed samples was performed with PBS + KB-T for supernatants. 
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APPENDIX I – PCR AMPLIFICATION SETUP AND PROGRAM METHODS 
        PCR Setup 
     Component Vol. (µL) 
 
PCR Method 
ddH2O 33.5 
 
95 
o
C 2 minutes Activation   
2 mM dNTPS 5 
 
95 
o
C 20 seconds Denaturing   
KOD 10x Buffer 5 
 
64.6 
o
C 10 seconds Annealing * 30 cycles 
25 mM MgSO4 3 
 
70 
o
C 5.5 seconds Extension   
10 µM Primer Mix 1.5 
 
70 
o
C 7.5 minutes Termination   
KOD Polymerase 1 
     DNA Template 1 
     
        Table 21:  PCR Method for TRNA-met-3 Promoter (DC3000) Amplification 
 
        PCR Setup 
     Component Vol. (µL) 
 
PCR Method 
ddH2O 33.5 
 
95 
o
C 2 minutes Activation   
2 mM dNTPs 5 
 
95 
o
C 20 seconds Denaturing   
KOD 10x Buffer 5 
 
56 
o
C 10 seconds Annealing * 30 cycles 
25 mM MgSO4 3 
 
70 
o
C 5 seconds Extension   
10 µM Primer Mix 1.5 
 
70 
o
C 7.5 minutes Termination   
KOD Polymerase 1 
     DNA Template 1 
      
Table 22:  PCR Method for Pyl-tRNA Amplification 
 
 
 
 
 
 
 
 
99 
 
 
   
PCR Setup 
     Component Vol. (µL) 
 
PCR Method 
ddH2O 33.5 
 
95 
o
C 2 minutes Activation   
2 mM dNTPs 5 
 
95 
o
C 20 seconds Denaturing   
KOD 10x Buffer 5 
 
69.5 
o
C 10 seconds Annealing * 30 cycles 
25 mM MgSO4 3 
 
70 
o
C 5 seconds Extension   
10 µM Primer Mix 1.5 
 
70 
o
C 7.5 minutes Termination   
KOD Polymerase 1 
     DNA Template 1 
      
Table 23:  PCR Method for Overlapping PCR of M. barkeri Pyr-tRNA with TRNA-met-3 
Promoter Region 
PCR Setup 
     Component Vol. (µL) 
 
PCR Method 
ddH2O 33.5 
 
95 
o
C 2 minutes Activation   
2 mM dNTPs 5 
 
95 
o
C 20 seconds Denaturing   
KOD 10x Buffer 5 
 
60.5 
o
C 10 seconds Annealing * 30 cycles 
25 mM MgSO4 3 
 
70 
o
C 30 seconds Extension   
10 µM Primer Mix 1.5 
 
70 
o
C 7.5 minutes Termination   
KOD Polymerase 1 
     DNA Template 1 
      
Table 24:  PCR Method for PylRS from pBK Amplification 
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PCR Setup 
     Component Vol. (µL) 
 
PCR Method 
ddH2O 33.5 
 
95 
o
C 2 minutes Activation   
2 mM dNTPs 5 
 
95 
o
C 20 seconds Denaturing   
KOD 10x Buffer 5 
 
63.1 
o
C 10 seconds Annealing * 30 cycles 
25 mM MgSO4 3 
 
70 
o
C 32 seconds Extension   
10 µM Primer Mix 1.5 
 
70 
o
C 7.5 minutes Termination   
KOD Polymerase 1 
     DNA Template 1 
      
Table 25:  PCR Method for PylRS from pJF118EH-mod1 Amplification 
PCR Setup 
     Component Vol. (µL) 
 
PCR Method 
ddH2O 16.75 
 
95 
o
C 2 minutes Activation   
2 mM dNTPs 2.5 
 
95 
o
C 20 seconds Denaturing   
KOD 10x Buffer 2.5 
 
56 
o
C 10 seconds Annealing * 30 cycles 
25 mM MgSO4 1.5 
 
70 
o
C 5 seconds Extension   
10 µM Primer Mix 0.75 
 
70 
o
C 7.5 minutes Termination   
KOD Polymerase 0.5 
     DNA Template 0.5 
      
Table 26:  PCR Method for M. jannaschii Tyr-tRNA from pLei-GFPuvN149TAG-Mj. Tyr-tRNA 
Amplification 
 
 
 
 
 
 
 
 
 
101 
 
 
PCR Setup 
     Component Vol. (µL) 
 
PCR Method 
ddH2O 33.5 
 
95 
o
C 2 minutes Activation   
2 mM dNTPs 5 
 
95 
o
C 20 seconds Denaturing   
KOD 10x Buffer 5 
 
69.5 
o
C 10 seconds Annealing * 30 cycles 
25 mM MgSO4 3 
 
70 
o
C 5 seconds Extension   
10 µM Primer Mix 1.5 
 
70 
o
C 7.5 minutes Termination   
KOD Polymerase 1 
     DNA Template 1 
      
Table 27:  Overlapping PCR of M. jannaschii Tyr-tRNA with TRNA-met-3 Promoter Region 
PCR Setup 
     Component Vol. (µL) 
 
PCR Method 
ddH2O 16.75 
 
95 
o
C 2 minutes Activation   
2 mM dNTPs 2.5 
 
95 
o
C 20 seconds Denaturing   
KOD 10x Buffer 2.5 
 
70 
o
C 10 seconds Annealing * 30 cycles 
25 mM MgSO4 1.5 
 
70 
o
C 15 seconds Extension   
10 µM Primer Mix 0.75 
 
70
 o
C 7.5 minutes Termination   
KOD Polymerase 0.5 
     DNA Template 0.5 
      
Table 28:  PCR Method for Amplification of lpp/Mj. tRNA/term Region from pLei vector 
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PCR Setup 
     Component Vol. (µL) 
 
PCR Method 
ddH2O 16.75 
 
95 
o
C 2 minutes Activation   
2 mM dNTPs 2.5 
 
95 
o
C 20 seconds Denaturing   
KOD 10x Buffer 2.5 
 
70 
o
C 10 seconds Annealing * 30 cycles 
25 mM MgSO4 1.5 
 
70 
o
C 15 seconds Extension   
10 µM Primer Mix 0.75 
 
70 
o
C 7.5 minutes Termination   
KOD Polymerase 0.5 
     DNA Template 0.5 
      
Table 29:  PCR Method for Amplification of proK/Mj. tRNA/term Region from pEvol Vector 
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APPENDIX II – DNA AGAROSE GEL IMAGES 
 DNA agarose gels for plasmid constructs, including PCR amplification, overlapping 
PCR, and ligation insert tests. 
 
Figure 39:  DNA gel for pLei-GFPuv N149TAG small-scale digestion with NheI and XbaI.  In 
both pLei-GFPuv N149TAG and pLei-GFPuv WT, proper band at 1.1 kb is cut, purified, and 
ligated to pBBR1MCS3 (XbaI).  Image shows non-digested (non) and digested (‘/.) products. 
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Figure 40:  DNA agarose gels showing initial PCR product of Pyl-tRNA (left; PylT) and 
properly-sized overlapping PCR product (right) of promoter/tRNA/terminator.   
 
 
Figure 41:  DNA gel for restrictions of vector (pBBR1MCS3-GFPuvN149TAG, left) and Pyl-
tRNA fragment (right).   
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Figure 42:  Ligation check for proper Pyl-tRNA insert in pSR6.067 ligation product.  Restriction 
of plasmids with HindIII to produce two bands (3.66 kb, 2.94 kb) if proper insert, otherwise three 
bands (3.66 kb, 1.64 kb, 0.995 kb) if no tRNA insert.  Lanes (left to right): 1, 1 kb ladder; 2, non-
digested sample #1; 3, digested sample #1; 4, empty lane; 5, non-digested sample #2; 6, digested 
sample #2; 7, non-digested sample #3; 8, digested sample #3. 
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Figure 43:  DNA gels showing PCR amplification products for pJF118EH-PylRS WT Construct 
(left image).  DNA gels (right image) showing digestion products for PylRS PCR fragment 
(EcoRI, XbaI), pJF118EH-mod1 (EcoRI, XbaI) and pML123 (BamHI, HindIII) 
 
 
Figure 44:  DNA gels showing digestion of pLei-PylRS Y348F (NheI, XbaI) for ligation into 
pML123 (NheI, XbaI). 
 
 
Figure 45:  PCR amplification of tac.PylRS
NAA
 cassette from pJF118EH-mod1 vector for 
digestion and insertion into pML123 (BamHI, HindIII). 
‘/. pLei-PylRS Y348F 
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Figure 46:  DNA gels showing digestion of M. jannaschii Tyr-tRNA promoter//tRNA, terminator 
overlapping PCR product (KpnI, PstI).  Band was excised, purified, and ligated into 
pBBR1MCS3-GFPuv N149TAG. 
 
 
Figure 47:  PCR product for amplification of BpFRS from pBK-BpFRS vector. 
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Figure 48:  DNA gels (left image) showing digestion of pML123 (11.6 kb; BamHI, XhoI) and 
digestion of pLei-TyrRS WT (BamHI, XhoI) to obtain T5.RBS.TyrRS WT fragment (2.2 kb).  
Also shown (right image) is test for proper insert after ligation of pML123 with T5.RBS.TyrRS 
insert (expected product is 2.164 kb for BamHI, XhoI digestion). 
 
                                                    
Figure 49:  DNA gels showing PCR amplification products for lpp (left) and proK (right) 
promoter//tRNA/terminator from respective parent plasmid. 
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Figure 50:  DNA gels showing digestion products of overlapping PCR products (0.3 kb lpp, left; 
0.5 kb proK, right) for insertion into pBBR-GFPuvN149TAG vector. 
          
Figure 51:  DNA gels showing digestion products for T5.AzFRS insert (left image; 1.3 kb from 
pLei) after ligation into pML123 (XbaI).  Miniprep from overnight colonies showed 2/8 
successful ligation reactions where insert was seen after BamHI, XhoI digestion (right image). 
 
110 
 
 
 
Figure 52:  Digestion of vector pBBR1MCS3-GFPuvN149TAG for insertion of lpp or pro 
promoter//tRNA/terminator cassette.  Reaction was performed overnight, followed by 
dephosphorylation with Antarctic phosphatase. 
 
